Familial hypercholesterolemia

E4_FH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E78.00 Hospital discharge: ICD-9 — 2720A Cause of death: ICD-10 — E78.00 Cause of death: ICD-9 — 2720A 2 out of 7 registries used, show all original rules.	7682
4. Check minimum number of events None	7682
5. Include endpoints None	7682
6. Filter based on genotype QC (FinnGen only)	6856

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF6v3

NAME	E4_FH
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E7800
HD_ICD_9	2720A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E7800
COD_ICD_9	2720A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Familial hypercholesterolemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Familial hypercholesterolemia, with ischemic heart disease

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	51090	24106	26865
Only index persons	48827	23192	25635
Unadjusted period prevalence (%)
Whole population	0.72	0.69	0.75
Only index persons	0.92	0.85	0.98
Median age at first event (years)
Whole population	68.34	71.31	65.66
Only index persons	68.32	71.27	65.66

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6856	2892	3964
Unadjusted period prevalence (%)	1.48	1.03	1.82
Median age at first event (years)	65.97	66.50	65.58

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7037: Matched controls
70370

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.8

322.5

2302

10464

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

4.7

313.0

779

1803

B01AC04

ATC

clopidogrel; oral

4.5

307.7

2426

7367

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

5.1

307.7

747

1590

I10

ICD-10 Finland

Essential (primary) hypertension

4.0

307.7

5811

38134

C10AX09

ATC

ezetimibe; oral

4.8

307.7

2277

6377

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.0

307.7

603

1079

C01DA14

ATC

isosorbide mononitrate; oral

3.6

307.7

2206

7986

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

5.2

307.7

1222

2719

C10AA05

ATC

atorvastatin; oral

4.2

307.7

4694

22610

I20.00

ICD-10 Finland

Unstable angina

7.0

307.7

585

895

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

15.3

307.7

1528

1250

AN1

Coronary angiography

5.1

307.7

1871

4626

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.9

307.7

2974

11135

I25.1

ICD-10 Finland

Atherosclerotic heart disease

4.1

307.7

3210

11970

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

10.9

307.7

3565

6059

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.1

307.7

2737

12081

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

4.0

307.7

2613

9059

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

5.3

307.7

1052

2261

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

5.0

307.7

1263

2948

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

53073.5

307.7

6994

215

C10AA07

ATC

rosuvastatin; oral

2.7

307.7

3034

15493

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.3

307.7

3049

13371

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

6.3

307.7

649

1114

211

Kela drug reimbursment

Severe hereditary disorders of lipid metabolism (familial hypercholesterolaemia and type III dyslipoproteinemia)

65.9

307.7

439

I25.2

ICD-10 Finland

Old myocardial infarction

4.4

307.7

1023

2648

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

27.5

307.7

636

253

C07AB07

ATC

bisoprolol; oral

2.7

307.7

4585

29027

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.3

307.7

1533

4246

C10AA01

ATC

simvastatin; oral

6.2

307.7

5323

23606

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

5.7

307.7

709

1357

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

4.9

307.3

727

1613

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.7

303.9

2416

11537

T90

ICPC

Diabetes non-insulin dependent

2.6

302.1

2504

12198

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

12.1

291.6

296

254

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.3

287.0

1299

4553

C10AA04

ATC

fluvastatin; oral

3.5

285.0

1104

3510

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.6

284.9

2417

11846

AN4

Balloon angioplasty and drug eluding stent

6.1

282.8

516

905

103

Kela drug reimbursment

Diabetes, insulin-treated

2.5

281.6

2665

13735

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.4

281.2

778

1952

I20.09

ICD-10 Finland

Unstable angina

4.3

281.0

796

2033

A10BA02

ATC

metformin; oral

2.5

278.4

2785

14709

Angiography of the heart and coronary arteries

3.8

265.3

887

2550

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

254.3

2577

13571

B04AB02, ,

ATC

7.2

243.1

369

534

C03CA01

ATC

furosemide; systemic

2.3

239.8

3182

18695

A10AE04

ATC

insulin glargine; parenteral

3.2

234.0

1033

3539

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.1

233.4

1144

4168

I20.90

ICD-10 Finland

Angina pectoris, unspecified

4.9

228.3

527

1139

C10AA03

ATC

pravastatin; oral

3.5

222.9

852

2665

C10AA02

ATC

lovastatin; oral

4.4

220.7

581

1396

C09AA05

ATC

ramipril; oral

2.3

215.3

2492

13690

AN3

Balloon angioplasty and metallic stent

5.5

212.1

425

811

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.2

205.4

935

3249

C10AX13

ATC

evolocumab; parenteral

29.5

204.9

136

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

202.2

1685

7998

C08CA01

ATC

amlodipine; oral

2.1

200.8

3487

22303

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.8

198.9

1148

4549

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

30.8

198.6

130

E86

ICD-10 Finland

Volume depletion

18.0

197.8

160

XF402

NOMESCO Finland

ECG with work load test

2.9

196.7

1060

4047

A10AB05

ATC

insulin aspart; parenteral

3.4

193.2

776

2496

205

Kela drug reimbursment

Chronic hypertension

2.1

192.3

2674

15650

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.4

191.5

775

2504

SPAT1262

SPAT

Handing over of treatment supplies

2.4

188.8

1679

8174

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.4

185.9

738

2354

E66.00

ICD-10 Finland

Metabolic syndrome

4.1

183.1

534

1382

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.7

182.2

630

1837

I20.01

ICD-10 Finland

Unstable angina

4.9

180.1

414

889

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

3.8

179.5

578

1605

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

5.1

176.1

386

796

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.0

175.1

864

3131

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

173.3

1893

10001

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.8

171.6

557

1554

ZXD05

NOMESCO Finland

Urgent procedure

2.1

168.8

2319

13369

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

165.7

3921

27335

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.9

165.1

518

1411

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

161.2

2457

14664

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

160.8

1669

8602

AA1

Conventional CABG

5.8

157.7

296

530

Single vessel balloon catheter extension

5.3

157.3

324

632

C07AB02

ATC

metoprolol; systemic

2.1

155.2

1922

10597

AA1AD

NOMESCO Finland

CT of head and brain

2.0

152.1

2502

15270

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

2.2

151.5

1722

9174

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.3

151.3

260

427

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

150.9

1561

8008

N02BE01

ATC

paracetamol; systemic, rectal

2.9

148.8

6428

54999

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

5.3

145.8

301

588

C10AC02

ATC

colestipol; oral

20.0

145.5

112

E87.6

ICD-10 Finland

Hypokalaemia

6.9

141.3

220

326

E87.5

ICD-10 Finland

Hyperkalaemia

10.3

140.6

158

157

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

3.0

136.6

648

2285

A28

ICPC

Limited function/disability NOS

2.0

132.7

1788

10081

SPAT1254

SPAT

Administration of medicine

2.2

130.7

1378

7080

A02BC02

ATC

pantoprazole; systemic

1.9

130.6

4980

39173

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

128.8

712

2726

A10BH01

ATC

sitagliptin; oral

2.5

128.6

924

4026

R06.0

ICD-10 Finland

Dyspnoea

1.9

127.4

2199

13471

A10AE05

ATC

insulin detemir; parenteral

3.3

125.7

493

1551

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

125.0

505

1618

388

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

+∞

124.3

119

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

122.8

2322

14617

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.6

122.8

423

1224

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.8

121.2

648

2435

280

Kela drug reimbursment

Clopidogrel

5.9

118.7

216

375

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

118.3

1450

7856

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

7.2

118.3

178

254

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.3

118.0

472

1502

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

117.9

1329

6979

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

117.4

2309

14673

292

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of familial hypercholesterolaemia

+∞

117.0

112

C10AB05

ATC

fenofibrate; oral

5.9

116.5

214

375

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.4

116.0

445

1379

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

4.6

115.5

284

642

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

5.4

113.9

227

429

E66.01

ICD-10 Finland

Obesity due to excess calories

2.9

112.4

553

1984

N03AX16

ATC

[U] pregabalin

1.9

111.2

1716

10053

J01DB01

ATC

cefalexin; oral

2.0

111.0

5685

47703

G47.3

ICD-10 Finland

Sleep apnoea

1.9

110.9

1668

9686

I25

ICD-10 Finland

Chronic ischaemic heart disease

3.0

109.1

518

1821

L28

ICPC

Limited function/disability (L)

1.9

106.2

1684

9932

C10AB02

ATC

bezafibrate; oral

6.2

103.1

177

290

N02AX02

ATC

tramadol; systemic, rectal

1.7

101.8

3168

22746

SPAT1263

SPAT

Sampling

1.7

101.8

2999

21216

B01AA03

ATC

warfarin; systemic

1.9

101.8

1822

11151

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.3

100.1

403

1285

A10AC01

ATC

insulin (human); parenteral

2.6

99.5

632

2584

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

99.5

2386

15912

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

97.6

1280

7056

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.4

96.0

249

587

R42

ICD-10 Finland

Dizziness and giddiness

1.8

95.5

1840

11481

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.8

95.3

2086

13517

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

94.5

622

2584

A10BJ06

ATC

semaglutide; parenteral

3.1

93.4

401

1328

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.9

93.3

462

1660

A10BK03

ATC

empagliflozin; oral

2.2

92.7

869

4215

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

3.3

92.3

367

1161

C03DA01

ATC

spironolactone; oral

2.1

92.2

1085

5742

B04AD02, ,

ATC

21.8

90.4

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

7.0

90.4

138

200

AN2

Balloon angioplasty, including several vessels

3.6

89.4

304

870

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

5.3

89.1

181

348

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

4.2

89.0

241

587

A10BB12

ATC

glimepiride; oral

2.4

87.0

671

2994

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

85.5

2970

21631

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

6.7

85.5

136

206

I50.0

ICD-10 Finland

Congestive heart failure

2.2

85.3

788

3793

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

6.3

83.3

142

231

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

83.2

1005

5355

A10BK01

ATC

dapagliflozin; oral

2.3

82.7

672

3065

R53

ICD-10 Finland

Malaise and fatigue

1.8

82.5

1723

10936

B01AB05

ATC

enoxaparin; parenteral

1.7

81.7

2373

16462

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

5.0

81.2

177

362

N02AA05

ATC

oxycodone; systemic

1.8

80.7

1635

10276

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

4.8

79.7

182

387

R07.3

ICD-10 Finland

Other chest pain

2.1

79.6

797

3956

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

79.2

1586

9928

C03AA03

ATC

hydrochlorothiazide; oral

2.1

79.1

808

4041

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

78.4

1117

6289

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

78.4

1318

7825

WX872

NOMESCO Finland

Intensive care

2.7

78.0

452

1760

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

12.1

78.0

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.5

77.5

275

809

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

77.3

1777

11554

C08CA13

ATC

lercanidipine; oral

1.9

77.2

1206

6994

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

76.6

2702

19597

E78.11

ICD-10 Finland

Other hypertriglyceridemia

16.6

76.2

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.9

75.3

1229

7221

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

75.3

2137

14671

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.9

75.2

226

594

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.6

74.5

178

393

N03AX12

ATC

[U] gabapentin; oral

1.9

74.0

1136

6543

M79.6

ICD-10 Finland

Pain in limb

1.6

74.0

2843

20996

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

72.5

379

1399

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.7

71.9

170

372

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

71.6

1146

6682

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

71.4

2657

19430

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.3

71.3

610

2838

2720A

ICD-9 Finland

Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA FAMILIARIS (FHK)]

+∞

70.9

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

4.7

70.8

166

361

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

4.1

70.1

194

480

C09AA02

ATC

enalapril; systemic

1.7

69.9

1603

10373

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.9

69.8

338

1197

A10BH05

ATC

linagliptin; oral

2.5

69.5

480

2032

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.4

69.4

501

2165

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

12.8

69.1

M10.9

ICD-10 Finland

Gout, unspecified

2.2

68.9

651

3151

M04AA01

ATC

allopurinol; systemic

1.8

68.7

1160

6870

160

Kela drug reimbursment

exenatide

4.3

68.7

177

415

E78.49

ICD-10 Finland

Other hyperlipidaemia

8.1

68.6

115

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.3

68.3

110

E66.8

ICD-10 Finland

Other obesity

3.1

68.1

294

975

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

7.5

68.1

133

B04AB01, ,

ATC

4.8

67.6

155

331

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

67.4

2362

16974

K90

ICPC

Stroke/cerebrovascular accident

3.1

67.2

298

1004

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.3

66.8

136

262

J01MA12

ATC

levofloxacin; systemic

1.7

66.3

1439

9156

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

66.1

1005

5754

T89

ICPC

Diabetes insulin dependent

3.3

66.1

260

816

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.3

65.8

255

793

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

65.2

1527

9910

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

65.0

2702

20141

SPAT1216

SPAT

Assessment of functional ability

1.7

64.6

1334

8364

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.5

64.5

161

368

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

3.9

64.2

190

494

SPAT1252

SPAT

Overall medication plan or its review

2.2

64.1

615

2991

J01FF01

ATC

clindamycin; systemic

1.6

64.1

1802

12250

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.3

64.0

492

2184

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

63.8

1296

8083

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.8

63.1

144

306

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

62.5

1162

7064

R55

ICD-10 Finland

Syncope and collapse

1.9

62.5

903

5081

A10AB04

ATC

insulin lispro; parenteral

3.6

62.2

208

588

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.1

62.1

264

868

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.1

62.0

260

848

R51.80

ICD-10 Finland

Headache

1.9

61.8

866

4822

H36.01

ICD-10 Finland

Diabetic maculopathy

5.0

61.8

134

273

M54.5

ICD-10 Finland

Low back pain

1.6

61.6

2225

16023

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

60.8

2086

14834

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

60.8

763

4094

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

60.6

590

2884

C02AC05

ATC

moxonidine; oral

2.5

60.2

384

1565

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

60.1

756

4059

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

60.0

568

2746

N30.0

ICD-10 Finland

Acute cystitis

1.8

59.5

1125

6863

207

Kela drug reimbursment

Chronic arrhythmias

1.7

59.3

1424

9273

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

3.2

59.1

234

737

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.8

59.0

109

192

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

58.9

874

4955

H02AB06

ATC

prednisolone; systemic

1.5

58.8

3249

25565

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

58.7

969

5677

B01AC07

ATC

dipyridamole; systemic

2.4

58.5

429

1864

Coronary artery bypass surgery

3.2

58.5

234

742

I20.91

ICD-10 Finland

Angina pectoris, unspecified

4.4

58.1

149

348

ZX120

NOMESCO Finland

Intravenous

2.0

57.8

676

3536

S18

ICPC

Laceration/cut

1.5

57.7

3379

26866

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

57.5

962

5658

R11

ICD-10 Finland

Nausea and vomiting

2.1

57.1

595

2984

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

56.8

1704

11710

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

56.7

1373

8946

UJF32

NOMESCO Finland

Coloscopy

1.6

56.6

1928

13644

A04

ICPC

Weakness/tiredness general

1.7

56.5

1099

6749

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

56.3

1513

10119

A29

ICPC

General symptom/complaint other

1.8

56.3

1045

6332

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

56.1

603

3057

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

56.1

1047

6355

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.2

55.7

151

368

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

3.6

55.3

183

514

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.7

55.0

297

1114

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

9.2

54.8

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.5

54.7

194

570

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

54.7

627

3253

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

54.4

630

3281

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

6.0

54.3

162

315

Kela drug reimbursment

Clopidogrel

4.6

54.2

128

280

J01MA02

ATC

ciprofloxacin; systemic

1.5

54.1

2770

21343

SPAT1325

SPAT

Vaccination

1.5

54.0

2486

18738

WX722

NOMESCO Finland

PEEP

2.4

53.8

380

1622

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

6.7

53.8

128

K29

ICPC

Cardiovascular sympt/complt other

2.3

53.7

418

1863

PE1AT

NOMESCO Finland

Femoral artery PTA

4.2

53.6

142

340

Catheterization and pressure measurement of the left side of the heart

3.6

53.5

180

511

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

53.4

416

1854

SPAT1097

SPAT

Recording of ECG

1.7

53.4

1131

7104

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

53.3

486

2312

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.1

53.0

233

781

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

52.9

458

2135

R03AC02

ATC

salbutamol; inhalant

1.5

52.8

3320

26597

A10BJ02

ATC

liraglutide; parenteral

3.3

52.7

199

609

SPAT1229

SPAT

Assessment of need for aid

2.0

52.6

654

3489

A10BX01

ATC

guar gum; oral

2.5

52.2

333

1356

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

51.9

964

5834

OAB50, ,

SPAT

2.0

51.7

628

3323

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

51.7

912

5437

SPAT1310

SPAT

Counselling related to known health issue

1.5

51.0

2107

15486

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

51.0

1229

7976

E78.10

ICD-10 Finland

Familial hypertriglyceridemia

110.9

50.8

A02BC05

ATC

esomeprazole; systemic

1.5

50.8

2605

20004

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

50.7

772

4401

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.5

50.5

125

284

C09CA01

ATC

losartan; oral

1.5

50.4

1918

13845

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.0

50.1

224

758

A46

ICD-10 Finland

Erysipelas

1.7

50.0

1157

7428

S97

ICPC

Chronic ulcer skin

2.0

49.9

551

2819

A06AD11

ATC

lactulose; oral

1.7

49.6

1191

7716

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

3.1

49.4

212

701

N06AX21

ATC

duloxetine; oral

1.9

49.3

683

3775

UKC02

NOMESCO Finland

Cystoscopy

1.6

49.2

1355

9079

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

49.2

907

5471

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

48.9

1226

8028

Z3231

NOMESCO Finland

Registered nurse

1.5

48.7

1787

12780

E78.2

ICD-10 Finland

Mixed hyperlipidaemia

16.5

48.7

N06AX11

ATC

mirtazapine; oral

1.5

48.7

2111

15639

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

48.5

822

4838

WX882

NOMESCO Finland

High dependency care

2.9

48.2

239

857

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

48.0

526

2681

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

48.0

4355

37109

XCH00

NOMESCO Finland

Eye pressure measurement

2.2

47.9

429

2026

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

47.8

2794

21928

ZXA05

NOMESCO Finland

Left side

1.5

47.8

1705

12112

C10AB04

ATC

gemfibrozil; oral

4.9

47.7

104

213

PEN23

NOMESCO Finland

Plastic repair of femoral artery

4.9

47.7

104

213

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

47.7

4218

35748

N19

ICD-10 Finland

Unspecified kidney failure

2.5

47.6

323

1354

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

47.5

3237

26136

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.5

47.5

115

257

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.0

47.5

585

3109

B01AC24

ATC

ticagrelor; oral

2.6

47.4

288

1145

SPAT1301

SPAT

No procedures

1.5

47.4

2214

16630

M48.0

ICD-10 Finland

Spinal stenosis

1.7

47.4

1000

6258

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

8.1

47.3

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.8

47.1

247

912

C08CA02

ATC

felodipine; oral

1.8

46.9

786

4606

R02

ICPC

Shortness of breath/dyspnoea

1.7

46.8

963

5984

H3603, E103,

ICD-10 Finland

7.7

46.7

N05CF01

ATC

zopiclone; oral

1.5

46.5

2205

16596

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

46.4

1101

7099

H25.8

ICD-10 Finland

Other senile cataract

1.7

46.3

1024

6484

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

46.2

542

2830

P01AB01

ATC

metronidazole; oral, rectal

1.5

45.8

2309

17579

N05BA04

ATC

oxazepam; oral

1.5

45.7

1653

11759

SPAT1255

SPAT

Intravenous administration of medicine

2.0

45.6

524

2717

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

3.8

45.5

140

374

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.6

45.3

149

417

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

45.3

205

699

A11CC03

ATC

alfacalcidol; systemic

3.3

44.9

172

531

ZXA00

NOMESCO Finland

Right side

1.5

44.9

1818

13238

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

44.2

800

4791

C09CA03

ATC

valsartan; oral

1.8

44.1

715

4146

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

43.9

439

2162

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

3.0

43.9

202

695

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

5.0

43.8

190

A02BC01

ATC

omeprazole; systemic

1.5

43.6

1851

13592

V03AE01

ATC

polystyrene sulfonate; oral

4.1

43.4

120

297

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

3.5

43.4

150

434

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.9

43.2

130

342

WX892

NOMESCO Finland

Monitored bed care

2.0

43.2

531

2816

Z3226

NOMESCO Finland

Physiotherapist

1.6

43.0

1123

7406

C07AG02

ATC

carvedilol; oral

2.0

42.9

478

2449

E78.40

ICD-10 Finland

Familial combined hyperlipidaemia

80.6

42.9

PD4AD

NOMESCO Finland

CT of lower extremity arteries

4.2

42.7

115

279

K92.1

ICD-10 Finland

Melaena

2.0

42.6

461

2338

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

42.6

936

5909

A10BD07

ATC

metformin and sitagliptin; systemic

2.3

42.4

328

1456

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

11.3

42.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

42.1

542

2919

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

42.0

603

3366

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3.6

41.8

136

378

E83.50

ICD-10 Finland

Hypercalcemia

6.0

41.8

122

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

41.6

400

1940

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

41.6

3055

24788

TK800

NOMESCO Finland

Hemodialysis

3.3

41.5

160

496

C09BA02

ATC

enalapril and diuretics; systemic

1.8

41.4

644

3684

Multi-vessel balloon catheter extension

6.0

41.4

123

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.1

41.3

172

559

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

41.3

733

4362

N05AH04

ATC

quetiapine; oral

1.6

41.3

967

6202

B01AF02

ATC

apixaban; oral

1.6

41.0

1113

7400

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

40.8

3754

31620

P20

ICPC

Memory disturbance

1.6

40.7

1261

8642

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

40.3

1100

7321

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

40.3

563

3115

162

Kela drug reimbursment

liraglutide

4.6

40.3

212

B04AC04, ,

ATC

5.4

40.1

148

A10AE06

ATC

insulin degludec; parenteral

2.7

40.0

214

799

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

40.0

269

1123

R07.2

ICD-10 Finland

Precordial pain

3.1

39.9

172

570

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

39.9

671

3928

111

Conventional CABG

4.8

39.9

186

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.4

39.7

142

420

A10AB01

ATC

insulin (human); parenteral

2.8

39.7

203

740

EBA00

NOMESCO Finland

Extraction of tooth

1.4

39.5

2213

17071

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

39.5

170

563

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

39.4

2287

17754

B04AC02, ,

ATC

6.7

39.4

XF404

NOMESCO Finland

Ambulatory ECG

1.8

39.3

604

3441

AP1

Catheterization of the left side of the heart

3.4

39.3

141

418

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.3

39.3

106

J01AA02

ATC

doxycycline; systemic

1.4

39.2

5049

44919

L17

ICPC

Foot/toe symptom/complaint

1.4

39.0

1945

14681

SPAT1153

SPAT

Removal of sutures

1.4

38.9

2229

17252

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

38.8

315

1428

B04AD01, ,

ATC

11.5

38.7

J01CA04

ATC

amoxicillin; systemic

1.4

38.6

5071

45193

K02.1

ICD-10 Finland

Caries of dentine

1.4

38.4

3292

27288

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.2

38.3

154

490

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

38.3

848

5354

Z71.8

ICD-10 Finland

Other specified counselling

1.4

38.1

1874

14092

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

38.1

2596

20694

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

38.0

1027

6809

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

37.9

551

3085

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.0

37.7

107

270

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.1

37.6

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.2

37.6

150

475

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

37.4

2841

23046

A10BJ05

ATC

dulaglutide; parenteral

3.3

37.3

142

437

A02BC03

ATC

lansoprazole; oral

1.4

37.3

1865

14059

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

37.3

354

1708

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

37.1

548

3083

-1, ,

NOMESCO Finland

1.5

37.0

1739

12953

M10.0

ICD-10 Finland

Idiopathic gout

2.3

37.0

293

1314

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

5.8

37.0

116

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.1

37.0

106

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.4

36.9

252

1059

C08CA05

ATC

nifedipine; systemic

1.9

36.8

467

2501

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.3

36.8

139

426

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

3.0

36.7

162

545

AA2

Off pump CABG sternotomy

6.0

36.6

107

FL1AC

NOMESCO Finland

Left cardioangiography

3.2

36.6

150

483

M03BX02

ATC

tizanidine; oral

1.4

36.4

3490

29355

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

36.3

1363

9708

L03

ICPC

Low back symptom/complaint

1.5

36.2

1690

12564

WZC30

NOMESCO Finland

Teaching

1.6

36.2

1094

7438

Z50.1

ICD-10 Finland

Other physical therapy

2.1

35.9

364

1800

A10BX07

ATC

[U] liraglutide

4.1

35.9

100

249

I20.10

ICD-10 Finland

Angina angiospastic

6.5

35.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

35.5

677

4102

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

35.3

1026

6909

K78

ICPC

Atrial fibrillation/flutter

1.7

35.1

681

4145

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

35.0

464

2520

K76

ICPC

Ischaemic heart dis without angina

2.5

35.0

226

926

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

34.7

291

1336

E66.9

ICD-10 Finland

Obesity, unspecified

2.7

34.6

192

730

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

34.4

330

1599

C09AA04

ATC

perindopril; oral

2.0

34.3

393

2031

K28

ICPC

Limited function/disability (K)

2.6

34.2

201

787

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

34.1

289

1333

A11

ICPC

Chest pain NOS

1.8

34.1

585

3440

A10BH02

ATC

vildagliptin; oral

2.8

34.1

170

612

SPAT1236

SPAT

Informing family of child’s disability

2.9

34.1

166

590

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.4

34.1

199

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.6

34.0

208

830

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

34.0

846

5489

KMAK, ,

NOMESCO Finland

1.4

34.0

2742

22351

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.4

34.0

191

E78.21

ICD-10 Finland

Remnant hyperlipidemia

338.9

33.9

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.1

33.8

141

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.5

33.7

180

N06AB04

ATC

citalopram; systemic

1.5

33.7

1198

8421

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.8

33.7

165

588

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

3.2

33.7

134

424

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

33.6

809

5207

A10AA02, ,

ATC

2.6

33.5

205

818

K77

ICPC

Heart failure

2.5

33.5

222

920

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

6.8

33.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

33.4

1709

12892

CK2S4, ,

SPAT

3.1

33.3

137

442

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

33.2

2274

18036

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

33.1

1005

6826

A10AA01, ,

ATC

3.1

33.1

139

454

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.7

33.1

605

3621

A10BX04

ATC

[U] exenatide

4.4

33.1

191

A01

ICPC

Pain general/multiple sites

1.7

33.1

651

3976

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

33.1

666

4093

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

5.2

32.9

133

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

5.1

32.9

137

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

3.9

32.8

248

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

5.7

32.5

106

K84

ICPC

Heart disease other

2.3

32.4

239

1040

Z00.0

ICD-10 Finland

General medical examination

1.5

32.4

1265

9059

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

32.4

340

1704

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

32.3

324

1596

2720X

ICD-9 Finland

Disorders of lipoid metabolism, Pure hypercholesterolaemia[HYPERCHOLESTEROLAEMIA ALIA]

+∞

32.3

R50.9

ICD-10 Finland

Fever, unspecified

1.6

32.2

960

6491

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

32.2

438

2398

A98

ICPC

Health maint/preventive medicine

1.6

32.1

6327

59520

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

32.1

488

2768

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

32.0

197

789

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

31.9

1336

9698

G44.2

ICD-10 Finland

Tension-type headache

1.7

31.7

683

4271

E87.2

ICD-10 Finland

Acidosis

165.8

31.7

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

31.6

283

1334

XF409

NOMESCO Finland

Other special ECG

5.1

31.5

131

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

31.4

380

2001

N06AB10

ATC

escitalopram; oral

1.6

31.4

940

6362

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

31.3

605

3676

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

31.1

271

1264

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

31.0

1089

7623

SFA10

NOMESCO Finland

One-surface restoration

1.3

31.0

3103

26029

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

4.4

31.0

176

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

31.0

2391

19278

R4110

NOMESCO Finland

Physiotherapy

1.4

30.9

1655

12556

E83.51

ICD-10 Finland

Hypocalcemia

11.5

30.9

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

2.4

30.8

218

931

I50.1

ICD-10 Finland

Left ventricular failure

1.9

30.8

402

2172

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

30.8

213

901

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

30.8

160

589

ZXD00

NOMESCO Finland

Emergency procedure

2.4

30.7

210

883

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

30.7

3935

34217

Z01.2

ICD-10 Finland

Dental examination

1.4

30.6

2519

20501

NHQ40

NOMESCO Finland

Amputation of toe

2.8

30.6

150

535

R60.0

ICD-10 Finland

Localized oedema

1.6

30.5

893

6009

I20.08

ICD-10 Finland

Unstable angina

9.1

30.3

C10AX14

ATC

alirocumab; parenteral

30.9

30.3

A10BG03

ATC

pioglitazone; oral

2.5

30.3

190

768

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

30.2

2230

17838

H3601, E103,

ICD-10 Finland

5.8

30.1

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

30.0

407

2227

N18.0

ICD-10 Finland

End-stage renal disease

3.9

29.9

233

N06AX16

ATC

venlafaxine; oral

1.7

29.9

646

4041

C10AC01

ATC

colestyramine; oral

2.5

29.9

192

785

SPAT1234

SPAT

Support of social functional capacity

1.9

29.8

416

2296

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

29.8

1011

7022

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

29.7

420

2329

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

29.5

1541

11627

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

29.5

480

2777

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.9

29.4

135

SPAT1104

SPAT

Monitoring of emergency patient

1.8

29.3

457

2611

TFP20

NOMESCO Finland

Cardiodefibrillation

1.7

29.2

566

3440

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

29.2

457

2614

J01DA01

ATC

[U] cefalexin

1.3

29.1

3729

32303

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.4

29.1

206

880

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.1

29.1

285

1392

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.2

29.1

114

358

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.7

29.0

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.0

28.9

203

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

28.8

464

2675

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.9

28.8

354

1875

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

28.8

1118

7980

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.7

28.6

158

600

C09DA06

ATC

candesartan and diuretics; oral

1.8

28.6

493

2899

R4110, ,

SPAT

1.5

28.5

887

6045

N06AA09

ATC

amitriptyline; systemic

1.7

28.4

597

3707

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

28.4

634

3998

A02BA02

ATC

ranitidine; systemic

1.4

28.2

1277

9383

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.8

28.1

435

2480

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

28.0

2078

16589

J01CA08

ATC

pivmecillinam; oral

1.4

28.0

2043

16269

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

27.9

1406

10526

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

27.7

189

795

XA800

NOMESCO Finland

Neuropsychological investigation

2.3

27.7

211

932

H3603, E113,

ICD-10 Finland

4.1

27.6

188

B01AC06

ATC

acetylsalicylic acid; oral

2.1

27.6

263

1271

CLA10, ,

SPAT

7.1

27.5

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.3

27.4

201

873

XF640, ,

NOMESCO Finland

2.3

27.4

204

892

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.0

27.2

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

27.2

716

4697

R03BB04

ATC

tiotropium bromide; inhalant

1.6

27.1

746

4943

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.4

27.1

XCK00

NOMESCO Finland

Perimetry

1.8

26.8

445

2588

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.6

26.8

622

3958

WVA30, ,

SPAT

1.7

26.8

469

2770

H3600, E103,

ICD-10 Finland

5.1

26.8

111

K92

ICPC

Atherosclerosis/periph vascular dis

2.9

26.8

123

424

R2110

NOMESCO Finland

Giving the first information

1.9

26.7

329

1743

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

26.5

193

835

C08DB01

ATC

diltiazem; oral

1.8

26.5

400

2261

R31

ICD-10 Finland

Unspecified haematuria

1.5

26.5

801

5421

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.8

26.5

212

SPAT1260

SPAT

Consultation of another employee

1.5

26.4

1111

8038

A10AB06

ATC

insulin glulisine; parenteral

3.9

26.3

195

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

26.2

878

6074

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

26.2

440

2569

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

26.1

2267

18484

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

26.1

308

1609

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

26.1

349

1901

BEF00, ,

SPAT

4.1

26.0

179

FXZ00

NOMESCO Finland

Off-pump cardiac operation

4.4

25.9

146

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

25.9

2301

18822

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

25.8

734

4897

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

6.1

25.8

SPAT1167

SPAT

Insertion of urinary catheter

2.0

25.8

272

1366

SPAT1240

SPAT

Therapeutic discussion

1.8

25.6

425

2471

I95.9

ICD-10 Finland

Hypotension, unspecified

2.8

25.6

128

462

M25.5

ICD-10 Finland

Pain in joint

1.4

25.6

1735

13623

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

25.5

624

4019

R06.2

ICD-10 Finland

Wheezing

2.0

25.5

267

1337

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

2.9

25.5

116

398

I20.88

ICD-10 Finland

Other angina pectoris other occlusion in coronary artery

6.7

25.5

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

25.4

272

1372

SPAT1081

SPAT

Cardiorespiratory global assessment

1.8

25.4

402

2305

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.3

25.4

285

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

25.4

386

2187

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

25.4

631

4081

K99

ICPC

Cardiovascular disease other

2.2

25.2

218

1014

A10AD05

ATC

insulin aspart; parenteral

2.6

25.2

143

551

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

25.2

164

675

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

25.2

354

1958

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.8

25.1

197

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

25.1

490

2981

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

25.1

1058

7653

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

24.9

1552

12015

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

24.8

544

3410

R52.2

ICD-10 Finland

Other chronic pain

2.2

24.8

218

1021

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

24.8

267

1351

C07AB08

ATC

celiprolol; oral

2.2

24.7

208

958

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.1

24.5

K74

ICPC

Ischaemic heart dis with angina

3.0

24.5

108

364

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

2.7

24.5

135

513

SPAT1059

SPAT

Spirometry at the office

1.9

24.4

330

1802

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

24.3

1643

12876

SPAT1285

SPAT

Provision of consultation response

1.8

24.2

343

1901

T82

ICPC

Obesity

2.3

24.2

178

775

C09DA01

ATC

losartan and diuretics; oral

1.5

24.1

720

4853

H3601, E113,

ICD-10 Finland

2.8

24.1

117

416

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

5.5

24.1

E0000UV, ,

ATC

1.3

24.1

2443

20305

C01BD01

ATC

amiodarone; systemic

2.1

24.0

223

1067

R52.9

ICD-10 Finland

Pain, unspecified

1.6

24.0

596

3851

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

24.0

746

5075

M01AH01

ATC

celecoxib; oral

1.4

23.9

1104

8113

H03AA01

ATC

levothyroxine sodium; systemic

1.4

23.9

1241

9312

P03

ICPC

Feeling depressed

1.8

23.8

364

2065

-2, ,

ICPC

4.3

23.8

139

Z2445

NOMESCO Finland

Psychologist

2.4

23.8

162

681

K01

ICPC

Heart pain

2.9

23.8

108

370

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

3.2

23.8

297

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

23.7

1087

7978

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

23.7

617

4032

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

23.7

146

586

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

23.6

959

6883

SPAT1211

SPAT

Application of soft bandage

1.6

23.6

570

3660

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

23.6

739

5034

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

23.5

235

1157

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.1

23.5

222

1070

Z95.9

ICD-10 Finland

Presence of cardiac and vascular implant and graft, unspecified

5.6

23.5

R4180, ,

SPAT

3.0

23.4

101

336

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.5

23.3

236

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

23.3

200

928

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

23.3

455

2768

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

7.0

23.3

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

23.2

243

1217

SPAT1053

SPAT

Memory test

1.4

23.2

1192

8923

S06.0

ICD-10 Finland

Concussion

1.6

23.0

622

4099

R5110, ,

SPAT

1.6

22.9

582

3783

C02EA02, ,

ATC

1.8

22.9

343

1936

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

22.8

132

514

A99

ICPC

Disease/condition unspecnature/site

1.5

22.8

652

4352

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

22.7

424

2547

R04.0

ICD-10 Finland

Epistaxis

1.6

22.7

543

3479

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

22.6

818

5735

PD5AD

NOMESCO Finland

CT of aorta

2.2

22.6

186

849

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.5

22.6

136

540

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.1

22.5

215

1041

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

4.3

22.4

133

XG466

NOMESCO Finland

Sleep oxymetry

2.2

22.4

198

930

N02BF02

ATC

pregabalin; oral

1.8

22.4

373

2171

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.1

22.4

227

1124

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

22.4

321

1787

SPAT1251

SPAT

Organisation of medication

2.0

22.3

236

1186

M01AX17

ATC

nimesulide; oral

1.4

22.3

1538

12063

J01EA01

ATC

trimethoprim; systemic

1.4

22.3

1472

11468

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.7

22.3

191

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.4

22.2

158

678

CKC15

NOMESCO Finland

Panretinal photocoagulation

3.8

22.1

178

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

4.7

22.1

110

SFA20

NOMESCO Finland

Two-surface restoration

1.3

22.1

3133

27101

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

7.0

22.0

C09CA06

ATC

candesartan; oral

1.4

21.9

1409

10929

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

21.8

384

2270

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

21.8

295

1612

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

21.8

502

3184

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.4

21.8

150

634

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.5

21.6

209

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.2

21.6

137

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.0

21.6

150

B04AB03, ,

ATC

8.7

21.5

R33

ICD-10 Finland

Retention of urine

1.5

21.5

622

4161

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.0

21.5

155

A12AA04

ATC

calcium carbonate; oral

3.0

21.5

316

J01FA06

ATC

roxithromycin; oral

1.3

21.4

2281

19001

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

6.2

21.4

R4120

NOMESCO Finland

Occupational therapy

1.8

21.4

342

1967

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

21.4

208

1014

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.2

21.4

275

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.5

21.4

206

A10BD03

ATC

metformin and rosiglitazone; systemic

2.6

21.3

120

461

L15

ICPC

Knee symptom/complaint

1.3

21.2

1488

11690

WX320

NOMESCO Finland

Spinalanesthesy

1.3

21.1

1573

12467

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.7

21.1

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

21.1

1456

11413

K22

ICPC

Risk factor cardiovascular disease

1.7

21.0

404

2446

S22.3

ICD-10 Finland

Fracture of rib

1.6

21.0

464

2913

E66.0

ICD-10 Finland

Obesity due to excess calories

3.4

21.0

223

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

21.0

333

1912

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.8

20.8

163

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

20.8

411

2508

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

4.4

20.8

120

A10BJ01

ATC

exenatide; parenteral

3.6

20.7

191

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

20.7

263

1408

E11.09

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - With coma

6.0

20.7

G04CA02

ATC

tamsulosin; oral

1.3

20.7

1945

15924

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

20.6

1005

7441

N03AX09

ATC

lamotrigine; oral

2.2

20.6

176

816

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.7

20.6

178

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

20.6

485

3094

SPAT1172

SPAT

Guidance concerning hydration

2.1

20.5

193

929

G63.2

ICD-10 Finland

Diabetic polyneuropathy

4.8

20.5

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.7

20.5

174

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

6.5

20.4

I70.0

ICD-10 Finland

Atherosclerosis of aorta

4.2

20.4

130

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.9

20.3

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

7.5

20.3

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.5

20.3

194

SPAT1360

SPAT

Extensive global examination

1.6

20.2

461

2916

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

4.1

20.2

131

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.4

20.2

138

582

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.2

20.2

127

A03

ICPC

Fever

1.5

20.2

777

5511

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

20.1

278

1530

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

20.1

540

3551

S29

ICPC

Skin symptom/complaint other

1.4

20.1

1257

9695

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.2

20.0

166

761

B01AC22

ATC

prasugrel; oral

5.1

20.0

CKC12

NOMESCO Finland

Photocoagulation of retina

1.9

20.0

263

1425

WW200, ,

SPAT

1.3

20.0

1927

15814

K07

ICPC

Swollen ankles/oedema

1.7

19.9

354

2098

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

19.9

587

3940

M01AB05

ATC

diclofenac; systemic, rectal

1.3

19.9

3893

34826

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

3.4

19.9

206

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

7.0

19.9

2722A

ICD-9 Finland

Disorders of lipoid metabolism, Mixed hyperlipidaemia

+∞

19.8

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

19.8

823

5922

WX290

NOMESCO Finland

Other blockage of nerve

1.3

19.7

2234

18711

N05AX08

ATC

risperidone; systemic

1.5

19.7

560

3730

L13

ICPC

Hip symptom/complaint

1.4

19.7

1221

9401

Z2221

NOMESCO Finland

Medical doctor

1.3

19.7

1468

11621

PA6AD

NOMESCO Finland

CT of neck arteries

2.0

19.7

219

1122

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.5

19.7

125

510

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

19.6

461

2938

TK810

NOMESCO Finland

Hemofiltration

4.5

19.6

105

N02BF01

ATC

gabapentin; oral

1.5

19.5

575

3859

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

19.5

521

3421

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

2.3

19.5

149

660

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

19.4

189

922

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

2.5

19.4

122

495

N18

ICPC

Paralysis/weakness

2.3

19.3

148

656

C07BB07

ATC

bisoprolol and thiazides; systemic

1.9

19.3

256

1390

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.9

19.3

244

1305

A10BG02

ATC

rosiglitazone; oral

2.6

19.3

111

432

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

19.3

275

1529

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.7

19.2

163

PD3AT

NOMESCO Finland

Pelvic artery PTA

4.2

19.2

119

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

19.2

348

2074

I47.2

ICD-10 Finland

Ventricular tachycardia

2.3

19.2

144

633

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

19.1

178

854

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

3.4

19.1

202

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.2

19.1

N05CD07

ATC

temazepam; oral

1.4

19.0

774

5544

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.8

18.9

302

1736

WW500

NOMESCO Finland

Blood transfusion

1.8

18.9

264

1458

ZX120, ,

SPAT

2.7

18.9

103

390

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.3

18.8

136

588

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

3.4

18.8

194

I20.0

ICD-10 Finland

Unstable angina

3.3

18.8

219

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

18.8

1213

9393

D07AC01

ATC

betamethasone; topical

1.3

18.7

2168

18179

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.9

18.7

298

C10AA06

ATC

cerivastatin; oral

4.7

18.6

WX199

NOMESCO Finland

Other local analgesia

1.9

18.6

243

1314

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

18.6

438

2793

B01AF01

ATC

rivaroxaban; oral

1.4

18.6

913

6763

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.2

18.6

118

XG405

NOMESCO Finland

Education on PEF monitoring

2.7

18.5

366

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.5

18.5

537

3594

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

4.7

18.4

SFA30

NOMESCO Finland

Three-surface restoration

1.3

18.4

2333

19773

A10BB01

ATC

glibenclamide; oral

1.8

18.3

295

1701

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

30.1

18.3

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.0

18.3

197

998

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.5

18.3

109

432

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

5.2

18.1

SPAT1281

SPAT

Other administrative function

1.6

18.1

452

2923

C09CA07

ATC

telmisartan; oral

1.6

18.1

453

2931

C08CA07

ATC

nisoldipine; oral

2.7

18.0

365

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.0

17.9

262

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

17.9

173

843

F21, ,

ICPC

3.0

17.9

257

C07AB03

ATC

atenolol; systemic

1.6

17.8

408

2583

K30

ICD-10 Finland

Functional dyspepsia

1.5

17.8

585

4015

-69

ICPC

Other reason for encounter NEC

1.9

17.8

238

1296

C03BA11

ATC

indapamide; oral

2.0

17.8

190

960

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

17.7

2241

18964

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

2.6

17.7

374

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

17.7

187

V03AE02

ATC

sevelamer; oral

4.7

17.7

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

5.6

17.7

H53.4

ICD-10 Finland

Visual field defects

2.3

17.6

138

618

R10.0

ICD-10 Finland

Acute abdomen

2.0

17.6

180

895

H02AB07

ATC

prednisone; oral

1.4

17.5

791

5773

Z2446

NOMESCO Finland

Social worker

1.7

17.4

322

1930

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

7.8

17.4

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

17.4

178

886

R29

ICPC

Respiratory symptom/complaint other

1.6

17.4

364

2255

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

3.9

17.4

133

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

2.4

17.4

114

473

WZC30, ,

SPAT

1.5

17.3

518

3486

A10AD01

ATC

insulin (human); parenteral

2.5

17.3

112

461

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

17.3

218

1165

TK820

NOMESCO Finland

Peritoneal dialysis

5.0

17.3

H26.4

ICD-10 Finland

After-cataract

1.4

17.3

775

5647

Z00.8

ICD-10 Finland

Other general examinations

1.6

17.3

433

2803

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.7

17.2

327

1974

Z51.88

ICD-10 Finland

Other specified medical care

2.2

17.2

137

618

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.5

17.1

554

3793

M01AH02

ATC

rofecoxib; oral

1.4

17.1

799

5864

R06.5

ICD-10 Finland

Mouth breathing

1.5

17.1

470

3108

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.7

17.0

314

1881

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

17.0

670

4765

H02AB04

ATC

methylprednisolone; systemic

1.4

17.0

802

5896

C09DA03

ATC

valsartan and diuretics; oral

1.7

17.0

312

1868

L04AD02

ATC

tacrolimus; systemic

3.7

16.9

140

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.5

16.9

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

16.9

215

1153

I20.19

ICD-10 Finland

Angina angiospastic

5.1

16.9

PD1AE

NOMESCO Finland

Ultrasound examination of abdominal aortta

3.3

16.9

198

E78.8

ICD-10 Finland

Other disorders of lipoprotein metabolism

19.3

16.8

A12BA01

ATC

potassium chloride; oral

1.7

16.8

302

1797

R03BA05

ATC

fluticasone; inhalant

1.4

16.8

936

7072

A87

ICPC

Complication of medical treatment

3.3

16.8

184

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

16.7

120

519

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.1

16.7

220

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

16.7

2196

18644

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

16.6

802

5915

K91

ICPC

Cerebrovascular disease

2.5

16.6

103

416

PG2YT

NOMESCO Finland

Implantation of arterial endoprothesis not elsewhere classified

12.7

16.6

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.0

16.5

176

889

SPAT1359

SPAT

Use of symptom diary

2.1

16.5

156

754

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

16.5

654

4659

A10BX02

ATC

repaglinide; oral

2.6

16.4

354

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

16.4

738

5378

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

16.4

1357

10869

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.8

16.3

227

1253

ACC51

NOMESCO Finland

Release of median nerve

1.6

16.3

387

2472

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

16.3

787

5804

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

16.3

325

1988

127

Kela drug reimbursment

Transplant complication

2.9

16.3

271

N06AB06

ATC

sertraline; oral

1.5

16.3

493

3328

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.8

16.2

288

ZPB22

NOMESCO Finland

Autograft of vein

3.7

16.2

135

M01AE02

ATC

naproxen; oral, rectal

1.2

16.2

3094

27342

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

16.2

594

4168

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

16.2

424

2772

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.3

16.1

124

552

M79.1

ICD-10 Finland

Myalgia

1.4

16.1

712

5172

I95.2

ICD-10 Finland

Hypotension due to drugs

3.2

16.1

194

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

16.0

234

1311

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

6.0

16.0

U04

ICPC

Incontinence urine

1.6

15.9

415

2709

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.1

15.9

150

724

3025

Kela drug reimbursment

Calcium carbonate

4.2

15.9

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

15.9

330

2039

I63.8

ICD-10 Finland

Other cerebral infarction

3.0

15.9

242

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

4.5

15.8

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

3.4

15.8

166

I49.5

ICD-10 Finland

Sick sinus syndrome

1.7

15.8

288

1720

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

15.8

273

1607

R47.0

ICD-10 Finland

Dysphasia and aphasia

2.8

15.8

276

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

15.8

180

932

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

15.8

184

960

SPAT1312

SPAT

General health counselling

1.3

15.7

1822

15217

H3600, E113,

ICD-10 Finland

2.7

15.7

316

PFH59

NOMESCO Finland

Bypass from femoral or popliteal artery to distal anterior tibial artery

6.9

15.7

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

15.7

1285

10269

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

15.6

342

2142

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.1

15.6

149

723

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.0

15.6

165

832

N17

ICPC

Vertigo/dizziness

1.4

15.6

785

5832

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.6

15.5

358

R01AD09

ATC

mometasone; nasal

1.2

15.5

2255

19322

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

15.5

598

4237

R05

ICD-10 Finland

Cough

1.3

15.5

1192

9443

B03XA02

ATC

darbepoetin alfa; parenteral

2.2

15.5

131

607

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.6

15.5

323

2000

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

15.4

1636

13510

Z49.2

ICD-10 Finland

Other dialysis

3.7

15.4

126

H05BX01

ATC

cinacalcet; oral

3.9

15.4

117

L14

ICPC

Leg/thigh symptom/complaint

1.5

15.4

484

3292

R52.1

ICD-10 Finland

Chronic intractable pain

3.2

15.4

184

WX002

NOMESCO Finland

Sedation and analgesia

1.3

15.4

1131

8902

D07AC13

ATC

mometasone; topical

1.3

15.4

1602

13202

FWW96

NOMESCO Finland

Other reoperation on heart or major thoracic vessels

5.9

15.2

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

15.2

354

2251

WZA00

NOMESCO Finland

Concise certificate

1.6

15.2

313

1931

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.1

15.2

201

C09DA07

ATC

telmisartan and diuretics; oral

1.8

15.1

245

1416

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.6

15.1

R03AC03

ATC

terbutaline; inhalant

1.4

15.1

699

5115

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.2

15.1

125

574

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

15.1

1332

10744

N03AX14

ATC

levetiracetam; systemic

2.0

15.1

158

794

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

15.1

1427

11614

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

15.1

360

2304

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.6

15.1

346

137

Kela drug reimbursment

Uraemia requiring dialysis

3.5

15.1

147

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.3

15.1

108

467

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.6

15.0

349

2218

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

15.0

230

1308

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

15.0

1816

15230

J01MA14

ATC

moxifloxacin; systemic

1.5

14.9

518

3594

FM3CN

NOMESCO Finland

Heart perfusion isotope imaging both at rest and with exercise

5.4

14.9

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.3

14.8

168

ZXD20

NOMESCO Finland

Day surgery

1.4

14.8

650

4711

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

14.8

612

4388

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.0

14.8

168

869

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

5.0

14.8

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

3.0

14.8

215

XPX00

NOMESCO Finland

Intraoperative angiography

4.0

14.7

103

R06.4

ICD-10 Finland

Hyperventilation

2.7

14.7

292

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

14.7

403

2661

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

4.3

14.7

AB2

AVR bio, stent

3.2

14.7

174

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

14.7

679

4967

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

14.7

547

3848

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

14.7

643

4660

SPAT1139

SPAT

Nutrition survey

1.8

14.7

205

1134

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.4

14.7

102

435

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

14.7

2145

18364

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

4.6

14.7

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

14.6

365

2360

J45.8

ICD-10 Finland

Mixed asthma

1.9

14.6

173

907

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

14.6

716

5291

G04CB01

ATC

finasteride; oral

1.3

14.6

909

6978

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.0

14.6

167

866

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

14.6

168

873

27200

ICD-8 Finland

Congenital disorders of lipid metabolism, Hypercholesterolaemia essentialis sive familiaris

+∞

14.6

A06AC51

ATC

ispaghula, combinations; oral

1.7

14.6

277

1674

N03AG01

ATC

valproic acid; systemic, rectal

1.7

14.6

286

1743

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

14.6

1045

8190

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

14.6

161

825

ZX100

NOMESCO Finland

Oral

2.5

14.5

370

FNC50

NOMESCO Finland

Aorto-coronary venous bypass with five distal anastomoses

6.3

14.5

M54.3

ICD-10 Finland

Sciatica

1.6

14.5

318

1994

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.8

14.4

214

1206

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.6

14.4

372

2425

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

14.4

599

4302

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.5

14.4

392

2586

ZXA10

NOMESCO Finland

Bilateral

1.3

14.4

1115

8835

N05BA01

ATC

diazepam; systemic, rectal

1.4

14.3

704

5204

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

14.3

765

5734

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.9

14.3

168

879

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

14.3

1505

12404

H53.2

ICD-10 Finland

Diplopia

1.9

14.2

184

994

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

14.2

359

2329

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

6.2

14.2

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

14.1

396

2630

Z29

ICPC

Social problem NOS

2.2

14.1

116

532

P76

ICPC

Depressive disorder

1.8

14.1

229

1326

A08

ICPC

Swelling

1.6

14.1

360

2342

WZC00, ,

SPAT

1.4

14.0

804

6092

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

14.0

284

1746

B05DB

ATC

Hypertonic solutions

3.8

14.0

107

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

14.0

2228

19227

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

14.0

164

858

SPAT1284

SPAT

Extensive health certificate

2.0

14.0

139

686

I20

ICD-10 Finland

Angina pectoris

2.4

14.0

420

G45.3

ICD-10 Finland

Amaurosis fugax

2.1

14.0

127

606

RD211, ,

NOMESCO Finland

1.7

13.9

242

1428

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

13.9

132

640

D07AD01

ATC

clobetasol; topical

1.3

13.9

907

7009

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.8

13.8

197

1098

PEQ23

NOMESCO Finland

Insertion of endovascular graft into femoral artery

23.8

13.8

L08

ICPC

Shoulder symptom/complaint

1.3

13.8

1310

10656

P01

ICPC

Feeling anxious/nervous/tense

1.6

13.7

354

2308

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.6

13.7

340

2197

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

13.7

357

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

13.6

342

2215

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

13.6

329

2112

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

13.6

1013

7977

R06AE07

ATC

cetirizine; oral

1.2

13.6

2236

19349

H04AA01

ATC

glucagon; nasal, parenteral

2.7

13.6

270

L29

ICPC

Musculoskeletal sympt/complt other

1.5

13.6

512

3611

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

5.4

13.5

K87

ICPC

Hypertension complicated

1.9

13.5

180

983

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

13.4

241

1436

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

2.3

13.4

428

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.0

13.4

146

745

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

13.4

209

1197

ZY010

NOMESCO Finland

Hospital outpatient

1.8

13.4

194

1087

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.1

13.4

126

610

A10BX09

ATC

[U] dapagliflozin

3.0

13.3

185

Z51.5

ICD-10 Finland

Palliative care

1.4

13.3

653

4824

PC1BC

NOMESCO Finland

Extensive angiography of aorta and abdominal arteries

4.0

13.3

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

13.3

174

944

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.8

13.3

188

1045

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.6

13.3

283

1762

C01AA05

ATC

digoxin; systemic

1.4

13.3

586

4251

AA5PD

NOMESCO Finland

CT examination of brain pefusion

2.8

13.2

229

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

13.2

173

939

SPAT1101

SPAT

Orthostatic test

1.6

13.2

321

2064

N03AF02

ATC

oxcarbazepine; oral

1.9

13.2

155

812

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.2

13.2

106

482

J02AC01

ATC

fluconazole; systemic

1.2

13.1

1751

14804

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

2.5

13.1

322

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3032080) INR in Blood by Coagulation assay

4685

30980

2.53

285.82

22.7

17.7

1.36

1.34

inr

2.17

4185

26014

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3622

21609

2.39

274.02

4.3

3.1

1828.59

1505.80

ng/l

4.09

3233

18726

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3237

19141

2.28

240.30

2.9

2.1

193.79

227.54

u/l

1.67

3095

17908

(3013826) Glucose [Moles/volume] in Serum or Plasma

5075

36536

2.40

229.43

7.4

4.7

7.23

6.77

mmol/l

35.63

4935

34671

(3020682) Albumin/Creatinine [Ratio] in Urine

3441

21787

2.13

204.87

5.1

3.9

12.13

7.02

mg/mmol

7.09

2374

13238

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1117

4346

2.87

200.41

4.5

3.5

5.15

5.16

kpa

0.17

1064

4126

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3784

25005

2.11

199.24

6.3

3.8

64.09

81.40

ng/l

0.42

3114

19426

(3009343) pH of Capillary blood

1092

4223

2.88

198.00

4.5

3.5

7.41

7.42

2.35

944

3457

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

987

3655

2.98

193.45

4.2

3.4

1.66

1.97

mmol/l

1.61

737

2735

(3009508) Creatinine [Moles/volume] in Urine

3398

21888

2.07

187.88

4.4

3.3

7.05

7.47

mmol/l

7.78

2865

17898

(3012516) Albumin [Mass/volume] in Urine

3339

21382

2.07

187.48

4.4

3.3

63.64

41.25

mg/l

5.31

2386

13507

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1248

5436

2.58

177.71

3.8

2.3

0.44

0.52

e6/l

0.61

1217

5245

(3022313) Gas panel - Capillary blood

849

3035

3.04

176.35

4.6

3.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4489

32645

2.04

169.92

7.1

6.6

12.07

12.45

umol/l

0.98

4327

31021

(3023368) Bacteria identified in Blood by Culture

2978

19091

1.97

158.62

5.1

4.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3049

19713

1.96

158.32

3.4

2.6

59.79

63.28

u/l

1.21

2905

18113

(3044640) Blood type and Crossmatch panel - Blood

3066

19930

1.95

156.03

3.1

2.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

647

2227

3.10

142.41

3.7

2.8

24.50

24.97

mmol/l

2.22

635

2191

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3895

28029

1.87

139.43

3.4

2.8

—

estimate

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2750

17797

1.89

136.80

3.4

3.2

35.77

35.59

u/l

0.04

2597

16562

(3051387) C reactive protein [Mass/volume] in Capillary blood

454

1301

3.66

133.86

4.6

3.6

25.86

31.79

mg/l

2.77

358

906

(3040151) Glucose [Moles/volume] in Capillary blood

315

702

4.65

130.56

18.6

14.4

8.23

7.16

mmol/l

3.00

260

571

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1487

7907

2.12

128.83

8.3

5.0

1.08

1.02

mmol/l

8.17

1393

7271

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5633

46688

2.04

120.39

10.0

8.1

84.24

81.41

u/l

2.61

5395

43912

(3022948) Iron [Moles/volume] in Serum or Plasma

1825

10695

1.95

119.39

3.5

2.4

11.46

12.41

umol/l

7.83

1704

9785

(3031040) Bacteria [#/volume] in Urine by Automated count

5052

40497

1.88

117.70

7.1

4.9

1792.36

2445.68

e6/l

0.59

361

550

(3020779) Urea [Moles/volume] in Serum or Plasma

1146

5683

2.21

117.63

9.7

5.8

11.77

10.42

mmol/l

6.61

1092

5384

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4273

32649

1.79

115.61

10.4

6.4

1.21

mmol/l

0.29

3822

27637

(3000850) Epithelial cells [#/volume] in Urine

2341

15082

1.83

112.85

3.9

2.6

5.05

4.81

e6/l

0.43

2195

13637

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1618

9287

1.96

111.40

2.3

2.0

30.14

29.86

0.82

1580

9017

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1169

5962

2.15

111.29

3.2

2.3

6.69

7.42

ug/l

0.66

1007

5200

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1690

9977

1.91

106.31

3.5

2.4

2.29

2.26

g/l

0.98

1565

9065

(3027945) Reticulocytes/Erythrocytes in Blood

1451

8144

1.98

105.95

3.2

2.4

1.85

1.75

3.49

1292

7162

(3002582) Erythrocytes [#/volume] in Urine

3006

21188

1.73

104.08

4.9

3.4

70.64

95.06

e6/l

0.76

2546

16429

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

623

2495

2.64

102.37

2.2

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2515

16954

1.75

101.40

2.7

2.3

3.09

2.97

mg/l

1.73

2199

14455

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1574

9226

1.91

100.41

3.6

2.4

20.14

22.03

7.48

1471

8426

(3018010) Neutrophils/Leukocytes in Blood

3630

27144

1.70

99.50

6.5

6.2

59.76

58.31

10.16

3427

25680

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

654

2730

2.54

98.55

2.3

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5040

41275

1.78

98.50

6.2

4.7

3.15

2.21

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2399

16071

1.75

98.12

3.5

2.8

371.38

353.30

umol/l

12.28

2099

13758

(3024561) Albumin [Mass/volume] in Serum or Plasma

3787

28728

1.69

97.55

6.0

4.8

34.30

34.92

g/l

8.46

3571

26651

(3018095) Leukocytes [#/volume] in Urine

3205

23293

1.69

96.85

5.7

3.9

142.22

117.16

e6/l

0.64

2571

16942

(3028626) Oxygen [Partial pressure] in Capillary blood

448

1551

3.02

96.72

3.1

7.77

7.96

kpa

1.79

432

1519

(3022096) Basophils/Leukocytes in Blood

3630

27270

1.68

96.68

6.8

6.4

0.61

0.66

7.98

3382

25217

(3016502) Oxygen saturation in Arterial blood

1258

6929

1.99

95.95

8.0

7.2

94.68

95.34

2.53

1231

6670

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

592

2385

2.62

95.92

5.0

3.7

24.68

24.99

mmol/l

1.49

540

2167

(3019069) Monocytes/Leukocytes in Blood

3635

27374

1.68

95.43

6.8

6.4

9.05

9.15

1.26

3392

25316

(3006504) Eosinophils/Leukocytes in Blood

3624

27272

1.68

95.38

6.7

6.3

2.78

2.86

1.05

3378

25219

(3002030) Lymphocytes/Leukocytes in Blood

3681

27820

1.68

95.24

6.7

6.3

24.95

26.39

11.62

3477

26041

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1904

12017

1.80

95.08

5.9

3.8

355.67

502.65

ng/l

0.84

1611

10149

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5987

51952

2.02

94.71

6.4

4.3

1.48

1.25

mmol/l

82.95

5532

46213

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6346

56343

2.29

93.55

27.7

17.0

27.74

27.60

mg/l

0.13

5742

46989

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

417

1422

3.05

92.38

2.4

2.2

137.80

90.08

ug/min

1.22

284

786

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5224

43598

1.77

91.24

5.3

4.4

15.81

13.44

mm/h

18.62

4893

40055

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1808

11362

1.80

90.93

2.2

1.9

—

(3022621) pH of Urine by Test strip

935

4760

2.11

87.90

3.3

2.9

6.01

6.06

0.81

717

3347

(3003396) Base excess in Arterial blood by calculation

1326

7670

1.90

86.57

7.8

6.9

1.05

1.03

mmol/l

0.08

1076

6274

(3013115) Eosinophils [#/volume] in Blood

3931

30732

1.63

84.76

6.5

6.2

0.20

e9/l

1.08

3498

26524

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3748

29041

1.62

83.10

2.5

2.2

96.08

94.39

pmol/l

1.19

2106

15413

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3773

29316

1.62

82.43

9.4

5.9

1.21

mmol/l

0.04

3493

26665

(3026008) Bacteria identified in Urine by Culture

2764

19913

1.64

82.13

4.1

3.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1902

12458

1.72

81.19

1.9

1.7

1137.91

1160.92

nmol/l

0.51

1520

9252

(3021901) Oxygen saturation in Capillary blood

378

1313

2.99

80.92

3.2

2.8

88.84

89.28

0.59

363

1284

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2237

15334

1.67

80.40

3.0

2.5

—

(3001604) Monocytes [#/volume] in Blood

3809

29786

1.61

80.02

6.3

6.0

0.65

0.62

e9/l

9.88

3337

25259

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6091

53917

1.96

79.98

10.5

6.6

43.53

39.66

mmol/mol

145.14

5705

49113

(3006315) Basophils [#/volume] in Blood

3821

29920

1.61

79.68

6.3

6.0

0.04

e9/l

0.52

3354

25403

(3013650) Neutrophils [#/volume] in Blood by Automated count

4219

33833

1.62

79.66

9.4

9.3

4.59

4.26

e9/l

12.92

3765

29200

(3019198) Lymphocytes [#/volume] in Blood

3874

30470

1.60

79.00

6.4

6.0

1.87

e9/l

0.00

3505

26505

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3307

25114

1.60

77.69

3.8

2.8

150.18

158.36

ug/l

0.84

3052

22826

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1602

10146

1.75

76.42

3.6

3.1

0.81

0.82

mmol/l

3.74

1519

9462

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

628

2882

2.29

75.95

2.1

1.9

2.52

2.57

ug/l

0.03

557

2513

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

116

169

6.96

75.64

1.7

2.3

10.11

9.91

kpa

0.19

116

169

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

116

169

6.96

75.64

1.7

2.3

4.95

4.96

kpa

0.01

116

169

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3414

26298

1.58

74.20

2.7

2.3

77.12

79.79

nmol/l

6.35

3027

22985

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5891

51925

1.83

73.65

6.2

5.0

2.04

2.03

mu/l

0.19

5429

46568

(3019550) Sodium [Moles/volume] in Serum or Plasma

6473

58974

2.22

72.37

34.6

20.3

139.49

139.72

mmol/l

10.31

6394

57645

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2044

13993

1.65

72.22

1.9

1.8

42601537.46

29217009.64

pmol/l

0.34

1730

11271

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4259

34644

1.58

72.11

4.4

3.2

67.30

53.49

u/l

8.19

4025

31657

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5026

42572

1.63

71.27

4.6

4.0

14.95

15.05

pmol/l

1.85

4587

37925

(3019977) pH of Arterial blood

1281

7744

1.80

71.10

8.1

7.0

7.41

7.42

1.20

803

4359

(3023103) Potassium [Moles/volume] in Serum or Plasma

6475

59076

2.20

70.85

34.9

20.5

4.03

4.00

mmol/l

15.06

6390

57653

(3019150) Specific gravity of Urine by Refractometry

2087

14419

1.64

70.82

5.5

4.4

1.65

1.12

kg/l

0.39

1620

9547

(3021601) Nitrite [Presence] in Urine by Test strip

3945

31620

1.56

70.50

5.2

4.0

0.00

estimate

0.23

745

6799

(3042936) Bacteria identified in Isolate by Culture

1442

9044

1.75

70.44

2.4

2.0

—

(3009261) Glucose [Presence] in Urine by Test strip

4003

32248

1.56

69.48

5.3

4.1

1.48

0.36

estimate

0.35

689

6614

(3035350) Ketones [Presence] in Urine by Test strip

3980

32023

1.56

69.45

5.2

4.1

3.66

2.55

estimate

0.17

768

7037

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6116

54807

1.89

68.78

7.4

5.2

4.16

4.52

mmol/l

119.84

5749

49797

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6212

55997

1.93

67.88

8.2

5.9

2.31

2.62

mmol/l

122.45

5812

50615

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6071

54352

1.85

67.44

7.4

5.0

1.32

1.46

mmol/l

129.75

5647

48986

(3027801) Oxygen [Partial pressure] in Arterial blood

1262

7770

1.76

65.21

8.2

6.9

11.57

12.09

kpa

3.16

1223

7438

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1262

7773

1.76

65.11

8.2

6.9

5.09

kpa

0.01

1226

7454

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1790

12149

1.63

64.05

1.8

1.7

1.38

1.44

mg/l

0.32

1443

9499

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

6063

54478

1.82

63.52

26.8

16.9

71.08

74.99

ml/min/173m2

38.23

5778

50811

(3019225) pH of Specimen

1137

6871

1.78

62.39

6.5

3.8

7.37

7.35

3.55

874

4807

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6109

55080

1.83

62.39

7.2

5.5

6.46

6.02

mmol/l

86.74

5601

49181

(3044242) Glucose [Moles/volume] in Arterial blood

152

350

4.42

60.36

1.6

1.9

8.58

8.28

mmol/l

0.34

152

350

(3014111) Lactate [Moles/volume] in Serum or Plasma

981

5728

1.83

60.21

7.8

6.8

1.44

1.38

mmol/l

0.68

969

5606

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1053

6307

1.79

59.31

9.0

7.7

119.26

120.80

g/l

1.61

1048

6139

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

750

4033

1.96

59.29

1.9

1.7

—

(3015736) pH of Urine

3221

25283

1.51

59.08

4.7

3.6

6.24

6.27

0.74

2075

13702

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

501

2337

2.23

57.82

2.3

2.1

553.09

610.32

ug/l

0.16

483

2231

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6503

60164

2.07

56.76

36.7

22.9

91.67

81.52

umol/l

40.30

6430

59250

(3041096) Erythrocytes [Presence] in Urine by Automated

2200

16070

1.54

55.91

4.6

3.5

0.97

0.41

estimate

0.40

540

5341

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6425

59241

1.97

55.88

16.5

12.3

26.76

25.34

u/l

6.61

6266

56888

(3002032) Base excess in Venous blood by calculation

1039

6326

1.75

54.97

4.6

3.4

1.80

1.83

mmol/l

0.07

892

5505

(3021960) Folate [Moles/volume] in Serum or Plasma

2573

19492

1.50

54.76

1.9

1.7

18.89

20.14

nmol/l

3.89

2178

16044

(3008152) Bicarbonate [Moles/volume] in Arterial blood

762

4238

1.89

54.23

7.7

6.6

24.50

24.59

mmol/l

0.30

748

4052

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1054

6542

1.72

51.81

4.6

3.3

5.79

5.82

kpa

0.27

1029

6382

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

922

5520

1.77

51.47

3.4

2.9

260.16

228.16

ng/l

0.90

861

5043

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3039

24027

1.47

51.14

5.3

4.1

2.61

0.46

estimate

0.81

579

5630

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

785

4490

1.84

50.99

5.6

3.3

113.24

89.10

ng/l

6.44

683

3769

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

797

4589

1.83

50.65

1.8

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

427

1974

2.24

50.24

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

578

3001

2.01

50.21

4.4

3.0

24.89

25.19

mmol/l

1.17

557

2915

(3007461) Platelets [#/volume] in Blood

6512

60726

1.97

48.61

41.3

26.0

238.54

240.96

e9/l

2.24

6417

59197

(3010813) Leukocytes [#/volume] in Blood

6513

60739

1.97

48.60

41.4

26.0

7.27

6.83

e9/l

23.27

6399

58947

(3000963) Hemoglobin [Mass/volume] in Blood

6513

60743

1.97

48.53

41.6

26.2

131.00

134.26

g/l

50.74

6455

59834

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6512

60731

1.97

48.53

41.2

25.9

91.67

91.71

0.26

6455

59802

(3035941) MCH [Entitic mass]

6511

60730

1.96

48.32

41.1

25.9

30.33

30.47

7.47

6453

59798

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6511

60733

1.96

48.27

42.1

26.5

39.27

40.11

14.05

6454

59774

(3026361) Erythrocytes [#/volume] in Blood

6511

60736

1.96

48.22

41.3

26.0

4.35

4.44

e12/l

33.11

6393

58960

(3007853) Bacteria identified in Skin by Aerobe culture

1128

7257

1.66

48.14

2.1

1.7

—

(3012544) pH of Venous blood

1043

6588

1.68

47.73

4.7

3.4

7.38

0.68

700

3760

(3003181) Sodium [Moles/volume] in Urine

201

665

3.08

46.76

1.3

1.2

64.04

65.95

mmol/l

0.28

170

509

(3023520) Reticulocytes [#/volume] in Blood

1018

6447

1.68

45.99

2.8

2.6

71.10

67.07

e9/l

3.40

827

4857

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3376

27573

1.43

45.93

2.7

2.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

680

3840

1.85

45.79

9.4

8.6

23.96

24.35

mmol/l

2.21

663

3739

(3006184) Hemoglobin [Mass/volume] in Capillary blood

340

1492

2.34

45.20

2.2

125.78

128.74

g/l

1.32

278

1144

(3000991) Gas panel - Venous blood

883

5427

1.72

44.50

10.0

7.8

—

(3029937) Albumin [Presence] in Urine by Test strip

2457

19013

1.45

44.38

5.3

4.2

0.00

estimate

0.19

653

6155

(40761511) CBC panel - Blood by Automated count

6195

57170

1.70

44.31

24.9

15.5

—

5.29

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

578

3136

1.92

44.00

1.7

1.6

1.68

1.56

g/l

2.16

480

2673

(3045414) Leukocytes [Presence] in Urine

986

6285

1.66

43.24

2.8

2.0

0.00

0.01

estimate

1.55

145

1112

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

253

990

2.61

43.05

2.1

1.5

0.97

0.85

nmol/l

1.26

211

837

(40768797) Stomach Pathology biopsy report

1209

8142

1.59

42.29

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

760

4544

1.75

42.14

2.4

386.84

373.72

nmol/l

1.04

698

4169

(3037121) Protein [Mass/volume] in Urine

431

2147

2.07

41.79

4.2

3.0

424.66

518.21

mg/l

0.39

230

898

(42870588) Differential panel, method unspecified - Blood

2571

20276

1.42

40.97

6.3

6.2

—

(4146454) Self-monitoring of blood glucose

203

728

2.84

40.91

2.9

2.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

126

341

3.74

40.27

1.3

1.2

9.10

9.44

mmol/l

0.33

120

311

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1223

8346

1.56

40.18

6.8

5.0

33.36

33.00

0.53

875

5243

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

728

4411

1.73

38.33

10.2

8.4

1.33

0.07

723

4391

(3024354) Oxygen [Partial pressure] in Venous blood

869

5530

1.65

38.03

3.8

2.9

4.67

4.42

kpa

2.69

849

5388

(3003129) Base excess in Capillary blood by calculation

210

798

2.68

37.90

2.6

2.4

-0.02

0.64

mmol/l

1.65

195

777

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

996

6581

1.60

37.37

3.1

2.7

9.58

10.21

umol/l

0.34

885

5795

(3049717) Cytology report of Urine Cyto stain

535

2983

1.86

37.27

3.1

2.9

—

(3000330) Specific gravity of Urine by Test strip

569

3253

1.82

36.54

3.8

3.5

1.02

ratio

1.07

539

2946

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

594

3455

1.79

35.99

4.9

3.6

49.36

46.79

1.62

580

3405

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

430

2270

1.95

35.35

3.0

2.7

0.35

0.36

iu/ml

0.17

248

1223

(3020630) Protein [Mass/volume] in Serum or Plasma

897

5868

1.61

34.92

3.0

2.5

65.47

66.18

g/l

1.98

836

5266

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

925

6113

1.59

34.48

2.3

2.2

0.20

g/l

0.49

863

5695

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1197

8393

1.51

34.16

2.0

1.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

428

2302

1.91

33.26

4.5

3.8

1.42

1.37

mmol/l

0.50

419

2280

(3020876) Protein [Mass/time] in 24 hour Urine

187

735

2.59

31.58

2.1

2.3

1.15

1.10

g/24h

0.11

123

397

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

196

789

2.53

31.51

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

200

813

2.50

31.49

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1138

8022

1.50

31.39

3.8

4.5

244.61

247.79

u/l

0.28

1078

7580

(3007164) IgA [Mass/volume] in Serum or Plasma

1338

9750

1.46

31.20

1.6

1.5

2.62

2.66

g/l

0.28

825

5620

(3023183) Ammonium ion [Moles/volume] in Plasma

263

1221

2.20

30.55

3.0

2.3

32.42

34.17

umol/l

0.62

235

1078

(3024522) Salmonella sp identified in Specimen by Organism specific culture

195

796

2.49

30.44

1.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

254

1165

2.22

30.40

3.5

3.8

1.63

1.60

0.04

235

1029

(3019060) Gas panel - Arterial blood

670

4238

1.64

29.67

5.4

4.5

—

(3000034) Microalbumin [Mass/volume] in Urine

138

482

2.90

29.28

3.8

2.7

61.29

26.86

mg/l

1.21

109

337

(3026782) Osmolality of Urine

1615

12321

1.40

28.94

3.9

2.9

521.09

547.86

mosm/kgh2o

5.75

1448

10726

(3025468) Yersinia sp identified in Specimen by Organism specific culture

185

759

2.48

28.59

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1347

9992

1.43

28.20

4.2

3.2

2.52

2.13

e6/l

0.85

831

5056

(3015377) Calcium [Moles/volume] in Serum or Plasma

2674

22160

1.33

28.09

3.3

3.5

2.35

mmol/l

2.45

2392

19872

(3005988) Vibrio sp identified in Specimen by Organism specific culture

184

763

2.45

27.80

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

647

4123

1.63

27.74

3.1

2.9

10.39

10.67

g/l

0.74

608

3786

(3027923) C peptide [Moles/volume] in Serum or Plasma

101

304

3.36

27.59

1.3

1.06

1.21

nmol/l

0.65

223

(3030467) Casts [#/volume] in Urine by Automated count

2264

18345

1.35

27.57

4.5

3.3

0.40

0.47

e6/l

0.99

1834

13762

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

183

761

2.44

27.48

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

242

1139

2.16

27.19

1.1

1.3

210.63

327.69

titre

—

104

(3017143) Hepatitis C virus Ab [Presence] in Serum

715

4724

1.57

26.29

1.9

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

739

4928

1.56

26.08

2.0

1.7

1.66

1.53

3.12

618

4155

(3004119) Hemoglobin [Mass/volume] in Venous blood

624

4000

1.61

26.07

3.7

3.0

125.02

128.22

g/l

2.73

606

3883

(3014051) Protein [Presence] in Urine by Test strip

1910

15187

1.35

26.02

3.9

3.1

0.03

0.07

0.50

549

(3033658) Prothrombin time (PT) actual/Normal

1883

14942

1.36

25.99

4.9

4.0

84.64

84.77

0.07

1833

14624

(3028026) IgM [Mass/volume] in Serum or Plasma

519

3180

1.68

25.90

1.9

2.0

1.14

1.43

g/l

1.90

475

2875

(3045424) Erythrocytes [Presence] in Urine

520

3216

1.67

25.03

2.7

2.1

0.01

0.30

estimate

0.49

118

847

(3017732) Neutrophils [#/volume] in Blood

1029

7419

1.45

24.81

4.2

3.1

5.04

4.76

e9/l

0.31

820

6209

(3022145) Colonoscopy Study observation

962

6876

1.46

24.23

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

964

6904

1.46

24.02

1.4

1.3

457.89

517.13

titre

0.63

237

1542

(3008757) Leukocyte morphology finding [Identifier] in Blood

166

705

2.39

23.84

3.7

4.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

474

2902

1.68

23.69

5.2

4.8

1.50

1.59

1.53

463

2721

(3034860) Kappa light chains.free [Mass/volume] in Serum

404

2390

1.73

22.91

3.5

3.2

55.64

54.57

mg/l

0.08

368

2018

(3009445) Proteinase 3 Ab [Units/volume] in Serum

423

2535

1.71

22.89

1.3

1.6

12.99

19.05

iu/ml

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

403

2388

1.73

22.72

3.5

3.2

38.08

41.93

mg/l

0.63

368

2017

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

278

3.19

22.31

4.9

3.0

0.79

1.36

3.07

278

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

193

907

2.16

21.82

6.1

6.4

12.42

11.96

mg/l

0.62

176

830

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1440

11244

1.35

21.41

1.3

1.43

1.83

u/ml

0.80

405

2833

(36304419) Bacteria [Presence] in Urine

2094

17250

1.30

21.40

4.4

3.2

21.97

161.24

estimate

0.50

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

359

2095

1.75

21.36

3.4

3.1

2.42

5.41

ratio

1.09

266

1228

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1042

7731

1.41

21.19

2.1

1.8

—

(3047181) Lactate [Moles/volume] in Blood

323

1835

1.80

21.07

5.8

5.7

1.44

1.33

mmol/l

0.99

299

1608

(3032773) Endomysium IgG Ab [Titer] in Serum

114

434

2.65

20.66

1.1

—

(3037756) Immunofixation for Serum or Plasma

266

1433

1.89

20.58

1.4

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4825

44287

1.28

20.02

33.9

22.7

330.64

331.79

g/l

14.79

4803

43972

(3034770) Mitochondria Ab [Titer] in Serum

247

1319

1.90

19.64

1.2

840.00

965.75

titre

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

187

905

2.10

19.64

2.0

2.1

27.15

25.85

mg/l

0.13

321

(3044927) Protein electrophoresis panel - Urine

152

678

2.27

19.57

1.3

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

298

1692

1.79

19.49

1.4

1.5

23.22

18.49

iu/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

790

5665

1.44

19.31

1.9

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

247

1328

1.89

19.24

1.2

199.17

140.93

titre

0.43

118

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

320

2.87

19.21

1.4

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

320

2.87

19.21

1.4

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

320

2.87

19.21

1.4

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

320

2.87

19.21

1.4

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1139

8706

1.37

19.19

1.3

12.05

13.53

u/ml

0.14

427

3159

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1004

7520

1.39

19.16

3.5

4.3

12.92

25.79

ug/l

2.11

858

6276

(40768804) Tissue Pathology biopsy report

2751

23725

1.26

18.87

2.4

2.3

—

(3018418) pH of Serum or Plasma

2277

19204

1.27

18.80

5.5

3.8

7.39

7.40

3.02

1823

13809

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

358

2164

1.69

18.77

1.2

1.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

723

5129

1.46

18.68

4.2

2.6

57.75

63.77

ml/min/173m2

4.49

354

2113

(3014271) Vancomycin [Susceptibility]

364

2.72

18.68

3.2

2.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

298

1715

1.77

18.63

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

521

3470

1.54

18.31

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

439

2813

1.60

18.27

2.5

2.3

7.70

7.38

g/l

3.82

393

2506

(3016750) Collection duration of Urine

324

2.80

18.22

2.0

2.2

486.66

489.82

min

0.12

228

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

438

2807

1.60

18.21

2.5

2.3

4.29

4.19

g/l

1.23

393

2507

(3017181) Myelocytes/Leukocytes in Blood

783

5670

1.43

18.09

4.6

4.1

0.68

0.97

4.57

341

1765

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

437

2804

1.60

18.08

2.5

2.3

3.63

3.75

g/l

0.66

392

2501

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

357

2195

1.66

17.55

1.6

1.7

37.28

39.26

u/l

1.00

289

1901

(3008037) Lactate [Moles/volume] in Venous blood

281

1618

1.77

17.55

3.5

3.1

1.56

1.70

mmol/l

1.54

273

1576

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1407

11239

1.31

17.43

4.0

3.1

1.22

1.40

e6/l

0.24

897

6305

(3021440) Promyelocytes/Leukocytes in Blood

747

5403

1.43

17.34

4.6

4.2

0.07

0.10

0.88

310

1515

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

283

1639

1.76

17.32

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

154

3.59

16.92

1.8

2.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

300

2.79

16.71

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

300

2.79

16.71

1.3

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

317

2.73

16.68

2.3

1.8

3.25

2.48

u/field

0.19

206

(4024509) Urine culture

453

2986

1.55

16.67

2.3

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3046

26858

1.24

16.33

5.8

6.1

3.36

3.99

ug/l

0.47

2756

24090

(3027456) Digoxin [Moles/volume] in Serum or Plasma

287

1698

1.72

16.30

3.3

0.89

0.81

nmol/l

1.50

228

1371

(3007930) Methemoglobin/Hemoglobin.total in Blood

407

2650

1.57

15.82

5.6

5.1

0.85

0.87

0.41

401

2477

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

2638

1.56

15.30

2.6

2.3

2.81

2.91

g/l

1.08

358

2334

(46235355) HIV 1 and 2 tests - Meaningful Use set

832

6262

1.37

15.21

1.9

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

345

2.57

15.15

2.6

2.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

122

554

2.22

15.15

1.4

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

122

554

2.22

15.15

1.4

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

122

554

2.22

15.15

1.4

1.8

—

(3004775) Volume in Urine collected for unspecified duration

108

468

2.33

14.98

2.4

2.2

657.86

640.98

0.12

292

(3032057) Clostridioides difficile [Presence] in Stool

134

3.60

14.87

2.2

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

401

2639

1.55

14.87

2.7

2.8

—

(3025941) Bacteria identified in Stool by Culture

405

2688

1.54

14.46

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

817

6182

1.36

14.41

2.1

2.2

203.99

149.10

ug/g

1.07

624

4785

(3036489) Thrombin time

305

1897

1.64

14.36

2.0

21.18

21.30

0.10

263

1691

(3000570) Elastase.pancreatic [Mass/mass] in Stool

300

1860

1.64

14.31

1.4

243.21

264.23

ug/g

1.06

177

1119

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

128

608

2.13

14.23

4.5

2.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1165

9311

1.30

14.05

1.4

1.3

37.62

37.74

iu/ml

0.01

349

2750

(3025159) Blasts/Leukocytes in Blood

727

5433

1.38

13.84

4.9

4.3

0.33

0.24

0.12

284

1462

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

413

2.34

13.58

1.4

—

(40768446) Kidney Pathology biopsy report

153

3.28

13.49

1.7

1.6

—

(3042733) HLA Ab [Presence] in Serum

111

3.71

13.31

6.2

4.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

406

2755

1.50

13.07

3.4

3.1

4.34

4.40

pmol/l

0.48

359

2419

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

141

719

1.98

12.98

1.1

66.68

80.48

iu/ml

0.08

142

(3002079) Sodium [Moles/time] in 24 hour Urine

162

3.16

12.97

1.2

1.3

165.27

165.02

mmol/24h

0.01

162

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

554

3998

1.42

12.94

10.3

7.5

24.48

24.89

mmol/l

1.89

549

3963

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

423

2.29

12.87

1.4

—

(1616796) Gas panel - Central venous blood

232

1388

1.69

12.72

3.6

3.7

—

(3011985) Renin [Units/volume] in Plasma

128

636

2.03

12.67

1.4

154.80

58.71

mu/l

1.37

114

568

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

362

2422

1.52

12.47

2.4

2.3

9.64

10.36

g/l

2.44

312

2088

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

291

1855

1.59

12.43

1.4

—

(3000494) Fungus identified in Specimen by Culture

913

7174

1.31

12.37

1.6

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

273

1717

1.61

12.33

1.5

1.6

13413.04

14703.72

e6/l

0.14

192

1218

(3017354) Segmented neutrophils/Leukocytes in Blood

150

796

1.90

12.30

3.0

3.9

60.24

57.48

0.88

133

672

(3008295) Osmolality of Serum or Plasma

103

478

2.17

12.21

1.2

1.3

277.45

284.65

mosm/kgh2o

2.40

341

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

256

1589

1.63

12.20

2.4

3.69

3.59

g/l

0.44

244

1519

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

323

2.43

12.06

1.0

1.1

288.10

284.60

mg/l

0.16

286

(3020191) Ethanol [Moles/volume] in Serum or Plasma

336

2.40

11.99

1.8

1.2

1.40

1.22

promille

0.48

258

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

318

2.44

11.97

1.2

1.1

51.45

24.37

u/l

1.22

280

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

115

563

2.06

11.88

2.4

2.1

2.13

1.43

u/field

1.00

292

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

198

2.84

11.86

1.6

1.9

51.35

120.91

umol/l

2.21

103

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

322

2.41

11.66

1.2

1.1

124.22

82.68

u/l

1.43

284

(1761482) Bacteria [#/volume] in Urine by Culture

260

1644

1.60

11.51

4.1

4.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

350

2.33

11.41

2.1

1.5

101.41

86.34

umol/l

1.43

350

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

243

1526

1.61

11.08

1.3

1.2

12.18

38.61

u/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

238

1487

1.62

11.08

1.9

1.5

0.25

0.23

g/l

3.43

228

1418

(3016038) Potassium [Moles/volume] in Urine

223

2.66

11.04

1.1

31.49

38.08

mmol/l

1.47

183

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

244

1536

1.61

11.02

1.9

1.5

1.22

1.17

g/l

1.78

233

1464

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

113

566

2.01

11.00

1.3

1.2

1.54

1.49

nmol/l

0.18

501

(40760892) CBC W Ordered Manual Differential panel - Blood

1451

12239

1.23

10.83

5.2

4.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

237

3674

0.63

10.80

2.0

2.1

3.52

3.49

ratio

0.12

201

2974

(3005322) IgE [Units/volume] in Serum or Plasma

427

3039

1.43

10.79

1.3

213.19

274.13

u/ml

0.91

399

2796

(3009466) Valproate [Moles/volume] in Serum or Plasma

133

717

1.87

10.46

4.9

4.5

351.62

344.17

umol/l

0.25

112

603

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

390

2.19

10.43

1.3

1.2

2.20

2.24

mmol/l

0.12

370

(3020491) Glucose [Moles/volume] in Blood

390

2.19

10.43

1.6

2.0

7.54

6.90

mmol/l

1.02

260

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

117

607

1.94

10.34

1.2

1.3

305.56

283.93

pmol/l

0.27

103

512

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

697

5412

1.32

10.23

3.2

2.5

37.78

62.21

u/l

0.90

577

4586

(3038026) Centromere Ab [Units/volume] in Serum

480

2.06

10.18

1.2

24.31

60.76

u/ml

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

484

3558

1.39

10.16

3.1

2.6

0.63

0.62

0.22

484

3545

(3044889) 12 lead EKG panel

4427

41450

1.18

10.13

5.3

4.4

0.25

3296.72

—

125

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

152

2578

0.58

10.05

1.7

1.8

3.29

3.43

mmol/l

0.59

112

1875

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

347

2408

1.46

10.04

2.8

2.3

0.84

1.04

g/l

0.61

298

2019

(40758558) Short blood count panel - Blood

2044

17945

1.20

10.00

7.7

6.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

128

697

1.85

9.79

1.1

1.58

1.53

g/l

0.52

118

626

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

219

1384

1.60

9.78

1.5

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

131

3.07

9.75

1.3

1.17

1.18

mmol/l

0.14

131

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

115

607

1.91

9.68

1.4

1.3

—

nmol/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

228

1459

1.58

9.66

1.4

1.3

9.57

4.66

u/ml

0.37

229

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

155

900

1.74

9.58

3.6

2.5

374.59

1717.04

u/ml

1.16

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

220

1403

1.59

9.47

1.7

1.8

13.16

12.03

mg/l

0.86

205

1297

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

112

592

1.91

9.40

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

226

1453

1.57

9.40

1.3

1.2

3.17

5.51

u/ml

0.46

153

(3004616) Nuclear Ab [Presence] in Serum

132

736

1.81

9.37

1.4

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

139

788

1.78

9.34

1.5

1.7

4.32

4.82

mmol/24h

1.00

120

676

(44816559) Phosphatidylethanol [Mass/volume] in Blood

266

1776

1.52

9.33

1.6

0.32

0.30

mg/l

0.16

121

780

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

116

622

1.88

9.33

1.4

1.3

0.19

nmol/l

0.25

519

(3024471) HLA-A [Type]

119

3.12

9.31

1.0

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

117

631

1.87

9.24

1.2

43.63

36.68

u/ml

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

127

703

1.82

9.24

1.4

1.3

0.64

3.76

nmol/l

0.64

122

676

(3024932) HLA-DR beta [Type]

115

3.14

9.16

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

133

752

1.78

9.03

1.7

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

491

1.97

8.90

1.4

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

251

1675

1.52

8.85

3.7

3.2

2.17

1.83

index

0.35

152

864

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

204

1305

1.58

8.70

1.3

726.94

589.94

mg/l

0.67

194

1240

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

246

2.37

8.62

1.4

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

246

2.37

8.62

1.4

2.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

230

1516

1.53

8.60

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

499

1.94

8.51

1.3

1.2

302.28

336.68

nmol/l

0.84

397

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

10.02

8.51

6.5

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

107

577

1.87

8.49

1.2

63.63

64.90

u/l

0.07

494

(3002179) Metamyelocytes/Leukocytes in Blood

684

5435

1.29

8.43

4.5

4.1

0.59

0.72

1.17

296

1709

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

118

660

1.80

8.34

1.5

1.8

—

(3002256) Pathology report gross observation

1015

8455

1.23

8.34

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

196

1256

1.58

8.31

1.3

1.2

2.37

4.83

u/ml

0.68

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

242

1625

1.51

8.31

1.5

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

427

3181

1.36

8.29

1.4

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

174

2.60

8.15

2.1

2.2

63.31

56.20

umol/l

0.66

145

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

249

2.30

7.96

1.5

2.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

125

724

1.74

7.87

1.4

1.3

0.14

0.34

nmol/l

1.54

(21494890) Protein electrophoresis panel - 24 hour Urine

117

665

1.77

7.86

1.8

2.0

—

(40761536) Microorganisms panel - Urine sediment

376

5030

0.73

7.77

5.4

4.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

122

2.88

7.72

1.4

1.3

79.67

180.92

nmol/24h

0.83

122

(3001729) Color of Synovial fluid

4.09

7.52

1.5

—

(1761868) Lipid panel - Serum or Plasma

1994

17811

1.17

7.50

4.6

3.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

114

2.90

7.41

1.2

13.25

12.90

pmol/l

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

152

944

1.62

7.39

1.7

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

110

626

1.77

7.39

1.5

1.8

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

131

784

1.68

7.36

1.2

2.17

3.67

u/ml

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

180

1167

1.56

7.31

8.0

4.6

1185.33

1947.27

iu/ml

0.21

162

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

420

1.94

7.30

1.1

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

149

927

1.62

7.21

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

141

872

1.63

7.00

1.8

1.7

0.66

0.82

g/l

1.40

114

674

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

238

1654

1.45

6.94

3.5

3.2

1.88

1.62

mg/l

4.43

215

1454

(3003434) Protein [Mass/volume] in Pleural fluid

171

1110

1.55

6.93

1.7

1.5

31.07

32.41

g/l

0.72

161

999

(3024928) Oxygen saturation in Venous blood

218

1492

1.48

6.88

3.3

2.9

63.44

60.12

1.45

212

1439

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

473

1.85

6.82

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

275

1972

1.41

6.77

2.7

2.3

0.05

0.04

g/l

0.12

249

1743

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

176

1161

1.53

6.65

1.2

1.3

4.14

3.76

mmol/l

3.67

171

1094

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

220

1520

1.46

6.63

2.2

89.54

89.46

0.02

210

1473

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

225

2.23

6.58

1.5

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1681

14955

1.16

6.51

5.0

4.0

0.08

0.38

0.67

219

(3035880) pH of Pleural fluid

402

1.90

6.50

1.4

1.3

7.42

7.41

0.17

265

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

126

773

1.64

6.49

1.3

299.15

495.69

u/l

1.22

118

734

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

262

1885

1.40

6.35

2.0

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

197

2.29

6.33

35.6

27.0

115.99

112.59

ug/l

0.09

166

(3017509) Phencyclidine [Presence] in Urine

6.53

6.32

2.0

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

272

2.07

6.11

1.4

10.92

6.16

u/l

0.59

230

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

127

794

1.61

6.09

1.5

1.2

258.73

277.45

u/ml

0.28

471

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

449

3537

1.29

5.96

2.5

17.24

22.37

au/ml

0.57

280

(3034274) Bile acid [Moles/volume] in Serum --fasting

303

1.99

5.91

1.4

1.8

11.67

11.16

umol/l

0.04

222

(3006571) Granulocytes/Leukocytes in Synovial fluid

131

832

1.59

5.90

1.3

1.5

59.17

60.61

0.14

527

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.79

5.71

1.1

1.2

0.82

0.66

umol/24h

0.67

(3023199) Leukocytes [#/volume] in Pleural fluid

150

990

1.53

5.71

1.6

1.5

6302.59

2314.14

e6/l

0.38

125

703

(3041354) Potassium [Moles/volume] in Venous blood

123

776

1.60

5.71

2.3

4.15

4.08

mmol/l

0.82

123

768

(3010144) Erythrocytes [#/volume] in Synovial fluid

110

676

1.64

5.68

1.4

61082.00

172392.83

e6/l

2.09

451

(3028707) Methadone [Presence] in Urine by Screen method

336

1.91

5.65

2.6

2.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

223

1596

1.41

5.62

1.6

1.7

—

(3010503) CD19 cells [#/volume] in Blood

344

1.90

5.61

2.5

2.3

380.69

120.11

e6/l

0.57

330

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

309

1.95

5.61

1.3

1.2

—

(3017704) Immunofixation for Urine

337

1.91

5.61

1.4

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

125

796

1.58

5.59

1.4

—

(3042631) Mycobacterium sp identified in Specimen

151

1006

1.51

5.52

2.5

2.9

—

(3035285) Chloride [Moles/volume] in Venous blood

122

776

1.58

5.49

2.4

2.3

105.78

105.90

mmol/l

0.10

122

768

(3027135) IgG subclass 1 [Mass/volume] in Serum

561

1.68

5.45

1.6

1.4

6.59

6.99

g/l

0.42

403

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

516

1.71

5.44

1.2

8.07

7.73

mmol/l

0.38

435

(4062490) Immunoglobulin typing, IgG

547

1.69

5.41

1.6

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

176

1216

1.46

5.39

1.7

1.6

5.29

3.33

iu/l

1.09

423

(21494755) Public health laboratory ask at order entry panel

183

2586

0.70

5.36

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

365

1.84

5.31

1.4

29.07

29.32

u/l

0.02

309

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

247

2.03

5.27

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

317

1.90

5.23

1.3

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.05

5.21

1.1

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

561

1.67

5.20

1.6

1.4

0.41

0.44

g/l

0.31

401

(3028192) IgG subclass 2 [Mass/volume] in Serum

561

1.67

5.20

1.6

1.4

2.54

2.92

g/l

1.63

404

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

163

1119

1.47

5.17

1.4

1253.79

907.58

e6/l

0.19

141

907

(3033705) Calcium.ionized [Moles/volume] in Venous blood

119

765

1.57

5.14

2.4

1.20

mmol/l

0.36

119

757

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

169

1171

1.45

5.12

1.2

1.4

33.65

39.09

u/l

0.33

150

1001

(36660697) Celiac disease serology panel - Serum

481

3903

1.25

5.03

1.2

—

(3028433) Virus identified in Specimen by Culture

205

2.10

5.00

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

179

2.19

4.98

26.2

19.1

1268.72

1307.24

nmol/l

0.12

171

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

246

2.00

4.96

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

592

1.63

4.95

1.5

1.6

22.67

27.93

u/ml

0.27

114

(3017569) Oxygen content in Arterial blood

382

1.79

4.91

2.0

2.2

15.86

16.08

0.23

382

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

160

1107

1.46

4.90

1.4

29.68

23.96

e6/l

0.18

130

851

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2344

21683

1.12

4.77

4.9

22.87

21.96

2.03

1202

11917

(3044290) Cell count panel - Cerebral spinal fluid

148

1015

1.47

4.75

1.4

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

417

1.73

4.70

2.9

1.5

153.33

103.69

ng/l

1.62

417

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

223

1648

1.36

4.70

3.0

3.5

1532.82

1045.70

u/ml

0.18

196

1498

(3028308) Erythrocytes [#/volume] in Pleural fluid

133

895

1.50

4.70

1.6

1.5

119246.41

55649.38

e6/l

0.70

509

(3009214) Lutropin [Units/volume] in Serum or Plasma

151

1047

1.45

4.60

1.4

10.46

9.90

u/l

0.18

122

840

(3048929) Epstein Barr virus Ab [Presence] in Serum

167

1180

1.43

4.60

1.4

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

193

1400

1.39

4.57

2.5

214.13

201.75

1.01

179

1329

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

147

2.25

4.55

1.1

1.3

0.36

0.31

g/l

3.09

115

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

320

2504

1.29

4.55

2.8

3.6

583.61

1421.73

u/ml

0.97

286

2166

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.97

4.54

4.7

2.3

0.84

0.33

u/field

1.00

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

173

1235

1.41

4.50

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

123

2.36

4.47

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

123

2.36

4.47

1.4

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

313

1.83

4.47

2.4

2.2

236.44

75.42

ug/min

0.63

(21494815) CD4 cells/Lymphocytes in Specimen

418

1.71

4.40

2.3

39.83

37.88

0.44

410

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

138

950

1.46

4.38

1.7

1.4

25.30

18.08

u/ml

—

(3023420) DNA double strand Ab [Units/volume] in Serum

275

2121

1.31

4.37

2.0

1.7

13.08

7.54

iu/ml

0.97

491

(3019832) Treponema pallidum Ab [Presence] in Serum

285

2211

1.30

4.34

1.8

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

266

1.89

4.33

1.2

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

238

1.94

4.33

1.7

1.8

5296.83

14522.52

u/ml

—

(3024263) Appearance of Synovial fluid

324

1.80

4.31

1.7

1.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

177

2.10

4.31

1.2

1.1

4.60

5.00

u/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

399

1.71

4.28

2.3

2.4

32.48

28.78

iu/ml

—

(3051611) Lipemic interference index of Serum or Plasma

612

1.56

4.15

3.5

2.7

11.84

13.39

index

0.70

308

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

351

2814

1.26

4.13

1.2

112.75

116.44

u/ml

0.07

141

962

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.80

4.11

1.1

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

630

1.55

4.09

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

352

1.74

4.09

1.7

1.6

313.82

352.68

mu/l

0.38

274

(3004451) EKG impression Narrative

338

1.75

4.06

1.6

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

452

3738

1.22

4.02

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

240

1841

1.31

4.00

1.6

26.27

24.84

u/ml

0.07

322

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

377

1.70

4.00

1.3

1.2

100.05

110.82

pmol/l

0.64

377

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.43

3.96

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

222

1690

1.32

3.91

1.5

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

205

1.96

3.90

1.2

1.1

1483.02

1542.66

miu/ml

0.13

205

(3014148) Varicella zoster virus Ab [Titer] in Serum

449

1.63

3.89

1.2

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

176

1295

1.37

3.88

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

176

1295

1.37

3.88

1.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

564

4789

1.19

3.82

1.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

139

2.16

3.82

1.4

1.5

0.44

0.41

ug/l

0.13

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

247

1918

1.30

3.78

2.8

2.3

0.00

g/l

0.76

216

1647

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

12.01

3.76

1.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

129

908

1.43

3.70

2.7

2.5

—

(4035726) Immunohistochemistry procedure

656

5659

1.18

3.70

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

785

6871

1.16

3.68

4.0

3.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

326

1.72

3.68

1.1

4.28

12.07

nmol/l

0.91

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

334

1.71

3.66

1.4

1.6

9.15

6.10

u/l

0.60

264

(3021387) Prolactin [Units/volume] in Serum or Plasma

128

902

1.43

3.66

1.8

1.7

293.48

287.11

mu/l

0.08

123

838

(3050794) Legionella sp Ab [Presence] in Serum

3.50

3.60

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

230

1784

1.30

3.57

2.7

2.3

0.00

g/l

-0.00

215

1643

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

421

1.62

3.56

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4612

44576

1.10

3.55

32.1

21.0

14.09

13.81

31.84

4581

43845

(40761539) Cells [Type] in Urine sediment by Light microscopy

157

2.04

3.54

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

124

2.18

3.53

1.4

1.3

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

10.01

3.49

1.0

1.2

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

10.01

3.49

1.0

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

630

1.50

3.49

1.5

31.37

28.92

0.24

391

(40768441) Liver Pathology biopsy report

408

1.62

3.48

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

1441

1.33

3.48

1.4

—

(4198724) Urine methamphetamine measurement

2.37

3.47

2.2

1.8

—

(3016879) Cocaine [Presence] in Urine

102

696

1.47

3.47

2.1

1.8

—

(3033099) Centromere Ab [Titer] in Serum

125

2.16

3.47

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

2.16

3.47

1.3

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

244

1.81

3.42

1.1

1.06

1.07

ratio

0.37

196

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

4.55

3.42

1.7

1.2

0.60

1.00

u/field

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

194

1.91

3.42

2.9

2.5

0.62

mmol/l

0.05

194

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

380

1.64

3.39

1.6

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

282

2261

1.26

3.38

1.1

—

(3021788) Differential panel - Synovial fluid

167

1249

1.35

3.37

1.4

1.5

—

1.00

—

(3000764) Benzodiazepines [Presence] in Urine

107

743

1.45

3.34

2.1

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

167

1251

1.34

3.34

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

106

738

1.44

3.27

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

106

738

1.44

3.27

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

106

738

1.44

3.27

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

106

738

1.44

3.27

1.6

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

209

1622

1.30

3.27

1.7

1.5

19.83

2.52

iu/ml

0.42

337

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

8.58

3.26

10.0

4.4

1.76

2.48

g/l

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

8.58

3.26

9.8

5.3

341.00

411.57

umol/l

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

377

1.62

3.25

3.4

4.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

389

3244

1.21

3.24

1.4

1.3

57.87

58.13

au/ml

0.01

229

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

152

1129

1.35

3.23

1.0

1.1

16.40

9.31

eliau/ml

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

3.20

1.1

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

340

1.65

3.20

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

250

1.76

3.19

1.3

162.30

483.67

ug/l

0.76

130

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

388

1.60

3.15

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.96

3.13

1.2

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

165

1.94

3.13

1.0

1.1

99.41

92.68

0.85

124

(4211845) Urine protein measurement

327

1.66

3.12

4.6

3.4

—

(4015189) Microbial culture of sputum

208

1.83

3.11

2.1

2.5

—

(40768806) Pleura Pathology biopsy report

118

847

1.40

3.10

1.7

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

173

1.91

3.08

2.8

30.82

27.96

umol/l

0.84

140

(3008898) HLA-B27 [Presence]

161

1216

1.33

3.08

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

106

748

1.42

3.07

2.1

1.8

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

520

1.51

3.02

1.5

1.3

382.86

463.67

titre

—

(40767503) Oxygen content in Capillary blood by calculation

174

1335

1.31

2.99

3.1

2.4

15.96

16.29

0.69

168

1307

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.35

2.98

1.3

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

506

1.51

2.97

1.2

1.1

—

4.26

—

(40768443) Skin Pathology biopsy report

353

2945

1.21

2.95

1.3

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

507

1.50

2.94

1.4

1.3

45.56

80.28

titre

—

(21494814) CD8 cells/Lymphocytes in Specimen

227

1.77

2.93

2.6

1.9

29.52

31.07

0.25

227

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

207

1.79

2.85

1.1

1.37

1.13

u/l

0.37

(3023487) Leukocytes [#/volume] in Peritoneal fluid

237

1.73

2.84

2.0

1040.91

2688.03

e6/l

0.36

164

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

186

1452

1.29

2.83

1.3

—

(3028300) Cannabinoids [Presence] in Urine

105

752

1.40

2.83

2.1

1.8

—

(4195642) Thrombophilia screening test

611

1.45

2.81

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

201

1.80

2.80

11.0

6.7

69.04

71.88

0.25

155

(3003694) ABO and Rh group [Type] in Blood

1682

15663

1.10

2.77

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

115

840

1.38

2.77

1.8

1.4

157.88

153.69

au/ml

0.14

242

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.08

2.76

1.2

—

mmol/l

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

136

1021

1.34

2.75

1.2

54.96

43.13

u/ml

—

107

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

131

1.99

2.74

2.3

1.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

131

1.99

2.74

2.4

1.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

138

1.96

2.74

1.7

1.3

12.80

16.41

pmol/l

3.06

111

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

138

1.96

2.74

1.1

—

(3027944) Amphetamines [Presence] in Urine

103

740

1.40

2.74

2.0

1.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.00

2.72

4.6

5.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

6.00

2.69

1.8

1.3

27.72

31.21

umol/24h

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

146

1.92

2.69

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

146

1.92

2.69

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

157

1208

1.31

2.68

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.28

2.67

1.1

18.18

18.76

u/l

0.06

(3006462) Nitrate [Presence] in Urine

303

1.62

2.66

4.9

3.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

183

1.81

2.64

3.0

1.7

1.73

1.79

ratio

0.08

177

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.93

2.61

1.2

2.19

1.84

umol/24h

0.26

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.55

2.61

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

285

2363

1.21

2.58

4.1

4.0

104.70

98.16

u/ml

0.05

279

2272

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

345

1.57

2.58

1.7

2.6

486.06

524.48

e6/l

0.17

286

(3016228) CD19 cells/cells in Blood

223

1.71

2.53

2.8

1.9

10.66

7.81

0.46

217

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

151

1.86

2.46

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

144

1.88

2.45

2.7

2.4

3.78

281.80

ug/l

0.78

144

(3018572) Chloride [Moles/volume] in Blood

165

1298

1.28

2.42

8.5

6.7

104.50

105.22

mmol/l

1.13

159

1138

(3039000) Anion gap in Blood by calculation

165

1298

1.28

2.42

8.5

6.7

11.80

11.20

mmol/l

1.36

159

1138

(3036670) Protein [Mass/volume] in Synovial fluid

234

1.67

2.41

1.3

41.16

40.47

g/l

0.11

119

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

296

1.59

2.41

1.9

1.8

39.87

40.02

g/l

0.06

296

(3014891) Appearance of Pleural fluid

2.09

2.32

1.9

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

140

1.86

2.31

1.5

1.7

9.88

9.71

ug/l

0.06

140

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.04

2.31

1.8

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

128

981

1.31

2.30

1.2

1.51

g/l

0.00

128

981

(3017315) Amylase [Enzymatic activity/volume] in Urine

316

1.55

2.29

1.3

1.2

219.07

425.19

u/l

1.14

297

(1001926) Buprenorphine [Presence] in Urine by Screen method

579

1.40

2.27

2.0

1.8

—

(3026726) Creatinine [Moles/volume] in Specimen

2.46

2.27

2.8

2.1

489.62

569.29

umol/l

0.07

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

2.46

2.27

1.5

2.3

62.57

59.19

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.23

2.27

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

285

1.58

2.27

1.6

2.4

14.96

17.50

nmol/l

1.14

268

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

149

1170

1.28

2.24

1.1

1.70

3.59

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.28

2.24

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

119

910

1.31

2.19

1.2

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.34

2.18

1.8

1.5

18.06

30.40

nmol/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

154

1220

1.27

2.17

1.4

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

897

0.70

2.14

1.1

0.63

0.62

ratio

0.03

156

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

204

1.67

2.13

1.9

1.8

23879.09

22429.14

e6/l

0.03

115

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

189

1.70

2.12

1.1

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.91

2.07

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.91

2.07

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.08

2.06

2.9

2.5

0.75

0.66

ug/l

0.28

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.03

2.05

1.3

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.11

2.02

1.1

1.3

6.69

6.75

mmol/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

104

791

1.32

2.02

1.1

—

(4281824) Cell count and differential, peritoneal fluid

562

1.37

1.96

1.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.08

1.96

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

185

1517

1.23

1.95

1.7

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

178

1455

1.23

1.94

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.19

1.94

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

258

1.55

1.91

3.1

3.8

79.04

70.56

mg/l

0.24

167

(3028679) Herpes simplex virus Ab [Presence] in Serum

203

1.63

1.91

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

108

833

1.30

1.91

1.3

1.2

195.95

221.11

miu/ml

0.26

286

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

477

5354

0.88

1.90

1.5

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

178

1460

1.22

1.89

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.18

1.88

20.4

6.9

98.00

173.35

e6/l

—

(3021589) Normoblasts [#/volume] in Blood

2699

25943

1.07

1.85

15.2

11.7

0.00

e9/l

0.32

2251

21247

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.05

1.80

2.6

1.4

4.64

4.99

nmol/l

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

116

912

1.28

1.79

1.8

1.5

227.31

219.77

pmol/l

0.05

111

887

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

215

1.58

1.78

1.5

1.1

45.20

69.00

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

224

1891

1.19

1.78

1.2

0.70

1.07

u/ml

0.45

164

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

386

1.43

1.78

2.6

2.1

—

(3047189) Immunofixation for 24 hour Urine

296

1.49

1.76

1.6

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

337

1.46

1.76

1.8

2.0

89.00

44.36

umol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

921

8521

1.09

1.75

9.6

7.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

231

1959

1.19

1.75

1.2

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

147

1.70

1.73

1.2

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.92

1.72

1.3

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

307

1.47

1.69

2.5

1.9

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

133

1.73

1.69

2.5

12.18

7.21

mmol/l

1.32

(37021550) Renin [Units/volume] in Plasma --upright

104

1.83

1.67

1.1

1.3

99.94

56.59

mu/l

0.29

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

649

1.31

1.66

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

284

1.48

1.66

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

667

1.31

1.65

1.1

0.58

1.91

u/ml

3.22

386

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.98

1.64

1.5

1.2

7.90

7.72

mg/l

0.03

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

145

1185

1.23

1.63

1.6

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

174

1451

1.20

1.61

1.2

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

1.91

1.59

1.1

1.2

43.33

55.08

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

175

1.60

1.57

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

439

1.37

1.57

1.4

1.5

—

(3020650) Glucose [Presence] in Urine

221

0.50

1.55

1.7

1.8

0.00

0.03

estimate

0.80

221

(44806071) Cardiolipin IgM antibody measurement

2.11

1.54

1.3

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

151

1248

1.21

1.54

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

502

1.34

1.51

3.0

2.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

659

1.29

1.51

1.1

49.52

20.67

au/ml

—

114

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

589

1.31

1.51

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.86

1.50

5.3

2.9

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.86

1.50

1.0

1.2

—

(40758358) Immune stain study

2.86

1.50

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.48

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

741

1.27

1.48

1.3

—

(40768800) Prostate Pathology biopsy report

164

1947

0.84

1.45

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.50

1.45

1.3

1.5

—

(21494434) Karyotype in Bone marrow

629

1.29

1.44

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

319

1.41

1.43

1.2

1.3

99.59

93.46

u/l

0.17

259

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.31

1.42

1.1

18.22

10.46

u/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

243

2111

1.16

1.42

1.8

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1423

13508

1.07

1.41

3.0

3.2

2.46

mmol/l

0.67

1232

12160

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

702

1.27

1.41

3.6

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

103

1.75

1.40

1.9

1.3

6.25

12.90

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.18

1.39

1.0

1.2

6.21

6.33

mmol/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

134

1.64

1.38

1.8

1.3

127.34

60.77

mg/l

0.20

100

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

158

1.58

1.37

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.20

1.36

1.2

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

2.20

1.36

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

777

1.25

1.36

1.3

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

105

1.72

1.32

1.4

3.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

126

1043

1.21

1.31

1.3

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

308

1.40

1.31

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

427

0.68

1.29

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

525

1.30

1.29

1.0

1.1

0.89

1.10

u/ml

0.11

247

(3045788) Cell count panel - Pleural fluid

792

1.24

1.29

1.6

1.5

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.78

1.28

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

748

1.25

1.28

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.00

1.27

1.9

2.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.29

1.26

1.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

564

1.28

1.24

1.4

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

422

0.69

1.23

1.3

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2413

23350

1.05

1.21

2.2

1.9

1.55

1.28

mmol/l

18.24

2036

18664

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

101

1.68

1.19

1.7

—

(3034891) Synovial lining cells/cells in Synovial fluid

333

1.35

1.16

1.3

1.5

4.42

3.88

0.09

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

616

1.25

1.14

1.2

127.43

112.68

3.24

553

(3038177) Helicobacter pylori Ab [Presence] in Serum

671

1.24

1.12

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.26

1.10

1.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

294

1.36

1.09

1.1

347.86

303.39

mg/l

0.52

261

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

235

1.41

1.08

1.1

130.02

602.30

ng/l

1.02

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

177

1.47

1.07

1.1

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

177

1.47

1.07

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

177

1.47

1.07

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

177

1.47

1.07

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

177

1.47

1.07

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

541

1.26

1.07

1.0

1.1

3.51

3.98

u/ml

0.13

286

(3042111) Morphology [Interpretation] in Bone marrow Narrative

139

1189

1.17

1.06

1.4

1.5

—

(40757373) Influenza virus identified in Isolate

105

1.62

1.05

2.0

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

111

1316

0.84

1.04

1.5

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

679

6358

1.08

1.04

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

323

1.33

1.03

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.92

1.02

1.7

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.92

1.02

1.4

2.0

16.40

18.42

umol/l

—

(3035933) Granulocytes/Leukocytes in Blood

106

1258

0.84

1.02

3.4

59.91

58.38

0.77

106

1258

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.62

0.99

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

115

1.57

0.99

2.4

1.7

1.40

0.55

u/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

240

1.38

0.98

1.4

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

132

1.52

0.96

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

141

1.49

0.94

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

125

1.52

0.93

9.2

6.9

5.48

5.03

kpa

0.33

125

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

281

0.68

0.93

1.3

1.5

1.32

1.23

ratio

0.19

179

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

281

0.68

0.93

1.3

1.5

1.27

1.14

ratio

0.20

179

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

281

0.68

0.93

1.3

1.5

0.83

0.95

ratio

0.86

179

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1651

15931

1.05

0.92

3.3

3.5

0.77

0.80

ug/l

0.55

1159

11209

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.14

0.91

1.0

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.67

0.91

1.2

1.1

18.60

18.22

g/l

0.06

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

259

2860

0.90

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.79

0.87

1.4

1.6

—

(3012441) Differential panel - Pleural fluid

841

1.18

0.87

1.7

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

255

2310

1.11

0.86

1.8

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

212

1.37

0.86

1.1

1.2

0.50

0.52

ratio

0.56

128

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

275

0.69

0.85

1.3

1.5

—

(40768793) Breast Pathology biopsy report

103

1199

0.86

0.83

1.5

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.88

0.81

1.2

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

122

1.48

0.80

1.7

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

147

1.43

0.80

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

402

1.25

0.78

1.1

68.00

126.45

titre

—

(3051101) Glucose [Moles/volume] in Cord blood

123

0.57

0.77

4.4

6.1

9.84

8.49

mmol/l

—

123

(40768795) Lymph node Pathology biopsy report

658

0.82

0.74

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.84

0.73

1.0

1.1

0.12

0.03

u/ml

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.00

0.72

1.0

1.1

0.07

1.54

u/ml

—

(3025577) Chromium [Mass/volume] in Blood

506

1.21

0.72

2.0

2.1

1.86

2.18

ug/l

0.70

418

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

228

1.32

0.72

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.61

0.72

1.0

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

1.58

0.71

1.8

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.92

0.70

1.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.55

0.69

1.3

1.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.64

0.68

9.5

5.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

114

1004

1.14

0.67

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

561

0.82

0.66

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

237

0.72

0.65

1.2

1.6

—

(40762814) Titanium [Mass/volume] in Blood

146

1.37

0.63

1.8

2.4

2.56

3.80

ug/l

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

129

1.40

0.63

1.1

2.4

1.40

1.04

ug/l

0.31

123

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1114

0.88

0.62

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

324

1.24

0.62

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

324

1.24

0.62

1.4

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.67

0.61

1.2

2.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

226

1.28

0.61

1.6

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.60

0.0

1.1

—

14.31

—

(40763590) HLA-DQ beta [Type]

0.00

0.60

0.0

1.0

—

(3035715) Granulocytes [#/volume] in Blood

1067

0.88

0.59

3.4

3.3

4.21

4.30

e9/l

0.21

1067

(46236302) HLA-C [Type] by High resolution typing

0.00

0.59

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.59

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.59

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.59

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

232

0.73

0.59

1.2

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.71

0.57

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

679

1.15

0.57

1.2

3.24

4.28

u/ml

0.55

320

(3019174) dRVVT (LA screen)

1.67

0.56

1.3

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

374

0.80

0.55

1.6

1.4

109.24

193.81

pmol/l

2.09

374

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.62

0.55

1.3

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.54

0.55

1.9

1.7

44.90

49.55

umol/l

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

472

0.83

0.55

1.3

1.4

—

(1002224) Polysomnography panel

179

1642

1.09

0.54

1.1

—

(3025130) Human papilloma virus identified in Specimen

413

1.19

0.54

1.5

1.7

—

(3034426) Prothrombin time (PT)

147

0.68

0.53

1.1

1.3

27.40

28.83

—

147

(3028717) Thiamine [Mass/volume] in Blood

1.52

0.52

1.1

1.2

60.50

62.71

ug/l

—

(3005033) Fetal Nuchal fold Thickness US

226

0.75

0.52

1.2

1.5

1.09

1.28

1.10

165

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

100

1.40

0.51

7.2

6.7

9.19

9.99

1.11

100

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

278

1.22

0.51

1.0

1.1

7.04

10.35

iu/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

224

0.76

0.49

1.6

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.56

0.48

1.0

1.1

86.86

102.40

titre

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.40

0.48

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

152

1398

1.09

0.46

1.7

6.10

5.16

mg/l

0.23

119

1029

(3002619) Bacteria identified in Specimen by Culture

173

1.27

0.46

1.2

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.40

0.44

1.1

1.3

39.69

1123.24

ng/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.37

0.44

1.3

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

507

1.15

0.43

1.0

278.45

349.17

ng/l

1.51

333

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

507

1.15

0.43

1.0

671.73

723.98

ng/l

0.46

325

(3035320) C reactive protein [Mass/volume] in Body fluid

470

1.15

0.43

2.3

2.5

32.24

34.04

mg/l

0.13

352

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

166

1.27

0.43

1.2

35.00

35.37

0.01

111

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

368

1.17

0.42

1.3

1.5

0.20

0.23

nmol/l

0.23

265

(40765089) Chromosome analysis panel - Blood by G-banded

1.43

0.42

1.1

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.56

0.42

2.6

1.3

260.40

321.59

umol/24h

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

378

1.17

0.42

1.1

2.72

3.01

u/ml

0.09

163

(3025018) Bordetella pertussis Ab [Titer] in Serum

249

1.21

0.41

1.3

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

510

1.14

0.41

1.0

39.54

46.75

ng/l

0.67

330

(3002523) Influenza virus A Ag [Presence] in Specimen

573

0.87

0.41

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.47

0.40

1.4

1.2

—

(4133840) Spirometry

132

1.29

0.40

1.3

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.12

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.36

0.38

1.7

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.36

0.38

1.7

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.36

0.38

1.7

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

202

0.79

0.36

1.8

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

146

0.75

0.36

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

576

0.88

0.35

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

291

1.17

0.35

1.1

—

(4034850) Laboratory test

180

1914

0.94

0.35

11.0

11.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

124

0.73

0.35

1.1

—

144.00

—

(3000012) Reticulocyte production index

117

1083

1.08

0.34

1.7

2.2

0.92

0.90

0.16

725

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

200

0.80

0.34

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

863

1.09

0.34

1.4

23.41

28.32

iu/l

0.89

726

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.33

0.33

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

844

1.09

0.33

1.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

586

1.11

0.33

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

382

0.86

0.33

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

568

1.11

0.32

2.4

1.9

513.22

3737.51

u/l

2.05

220

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.33

0.32

1.0

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.33

0.32

1.5

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

143

0.77

0.32

1.3

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.30

0.31

1.0

3.55

12.88

u/ml

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.35

0.31

2.9

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

494

1.11

0.31

1.1

1.22

3.11

eliau/ml

3.05

167

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.32

0.30

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

129

1.24

0.30

3.2

2.7

2372.50

1080.01

u/l

0.41

122

(3010726) Horse dander IgE Ab [Units/volume] in Serum

486

1.11

0.29

1.1

0.95

0.93

u/ml

0.02

251

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

203

1.18

0.29

2.9

1.9

152.95

168.08

0.38

191

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

382

1.13

0.29

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

148

1.22

0.29

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.23

0.29

13.4

6.8

0.20

0.27

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

373

1.13

0.29

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

843

1.08

0.28

2.1

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

854

1.08

0.27

1.6

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

1.25

0.27

1.0

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

224

1.16

0.27

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.70

0.26

1.0

1.1

22.68

43.49

iu/ml

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

168

0.83

0.22

1.0

1.4

246.75

146.00

nmol/l

—

116

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

107

1.22

0.21

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

4.4

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.4

—

1.61

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

544

5564

0.98

0.21

2.6

2.2

11.43

13.06

nmol/l

4.97

462

4937

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

647

0.93

0.21

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

440

1.09

0.21

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

192

1.15

0.20

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.0

—

3.71

—

(3044007) Cell count panel - Peritoneal fluid

202

1.14

0.20

1.9

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

288

1.11

0.19

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

127

1.18

0.19

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.15

0.19

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

241

1.12

0.19

1.3

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

166

1.14

0.18

1.1

0.82

0.58

u/ml

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.15

0.17

1.3

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

688

1.06

0.17

1.1

1.2

1.68

4.93

u/ml

2.22

249

(4268621) Lupus anticoagulant assay

486

0.93

0.17

2.0

2.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

157

1.15

0.17

1.3

1.4

14.89

11.28

mm/h

0.32

157

(3014599) Egg white IgE Ab [Units/volume] in Serum

158

1.14

0.16

1.1

6.33

1.17

u/ml

—

(3012501) Base excess in Blood by calculation

140

1349

1.04

0.15

4.6

3.8

2.26

2.61

mmol/l

1.17

109

910

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

236

1.10

0.14

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

141

1.14

0.13

1.0

1.1

89.00

81.20

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

141

1.14

0.13

1.0

1.2

88.14

82.57

—

(3018333) Ribosomal P Ab [Presence] in Serum

346

0.92

0.13

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

278

1.08

0.12

7.9

4.1

33.83

56.29

u/ml

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

376

1.06

0.11

1.2

1.4

0.98

1.97

u/ml

0.69

224

(3008536) Aspergillus sp Ab [Presence] in Serum

134

1.12

0.10

1.1

1.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.14

0.10

1.6

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.11

0.09

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

1.09

0.09

6.6

8.0

124.80

34.36

mg/mmol

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

319

0.94

0.09

5.3

5.0

260.75

83.79

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

419

1.05

0.09

1.1

3.49

2.38

u/ml

0.42

207

(3029396) Erythrocyte agglutination [Presence] in Blood

1.11

0.09

1.7

2.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.09

0.08

1.2

2.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.07

0.08

1.0

—

(4212803) Bone marrow aspirate examination

1.05

0.08

1.2

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

127

1.10

0.07

1.6

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.83

0.07

1.7

1.5

—

(37208534) Antinuclear antibody arbitrary concentration in serum

147

1.09

0.07

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

699

1.03

0.07

1.1

—

(44806420) Estimation of glomerular filtration rate

458

0.96

0.07

2.8

2.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

265

1.06

0.07

1.4

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

163

1658

0.98

0.06

2.0

1.8

37.15

45.08

nmol/l

6.12

150

1590

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

356

0.95

0.06

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

202

0.94

0.05

6.7

93.70

281.33

ug/l

0.53

120

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

209

1.05

0.04

1.0

1.1

8.25

4.91

u/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

140

1.07

0.04

1.5

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.10

0.04

1.0

—

(44813793) Dust mix specific IgE antibody measurement

339

1.03

0.03

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

141

1.06

0.03

2.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

320

1.03

0.03

2.0

2.7

37.87

35.96

0.27

195

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

142

1.06

0.02

1.3

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

329

0.97

0.02

1.4

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

537

5389

1.00

0.02

4.5

3.4

1.23

mmol/l

0.08

479

4498

(3015076) Soybean IgE Ab [Units/volume] in Serum

133

1.05

0.01

1.0

1.00

2.86

u/ml

—

(40758292) HTLV I+II Ab panel - Serum

116

0.95

0.00

1.2

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

264

1.02

0.00

1.2

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

334

1.02

0.00

1.9

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

354

1.02

0.00

1.0

1.1

0.63

0.30

u/ml

0.34

136

(3022806) Fractional oxyhemoglobin in Capillary blood

774

1.01

0.00

1.9

1.6

88.98

89.04

0.03

759

(40765096) Chromosome analysis panel by Banding

243

0.99

0.00

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

464

0.99

0.00

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

132

1316

1.00

0.00

2.0

1.8

185.03

204.42

pmol/l

1.61

119

1236

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

372

0.99

0.00

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

372

0.99

0.00

1.1

—

(3000285) Sodium [Moles/volume] in Blood

159

1.01

0.00

1.4

1.2

135.94

138.94

mmol/l

1.81

129

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

169

1.01

0.00

1.8

1.6

53.80

52.97

ug/l

0.04

169

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

169

1.01

0.00

1.1

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

361

1.00

0.00

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.90

-0.00

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

19.00

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

32.40

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.02

-0.00

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.91

-0.00

1.1

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.8

—

5.67

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.9

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

71.17

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.92

-0.00

1.2

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

6.7

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

0.04

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

2.7

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

50.44

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_FH and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_FH	1.354 [1.23, 1.49]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.143

During the follow-up period (1.1.1998 — 31.12.2019), 6158 out of 21580 females with E4_FH died.

Males

Parameter	HR [95% CI]	p-value
E4_FH	1.442 [1.31, 1.59]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 7033 out of 24176 males with E4_FH died.

Mortality risk

Mortality risk for people of age

years, who have E4_FH.

N-year risk	Females	Males
1	0.123%	0.314%
5	0.761%	1.636%
10	1.933%	4.213%
15	3.509%	8.179%
20	6.254%	13.691%

Relationships between endpoints

↥

Index endpoint: E4_FH – Familial hypercholesterolemia

GWS hits: 29

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Familial hypercholesterolemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints